研究室紹介
Our Laboratories
研究室紹介
Our Laboratories
藤森 尚 業績
原著論文
Tanaka S, Ikenaga N, Ideno N, Fujimori N, Abe T, Matsuura T, Nakata K, Itoh S, Yoshizumi T, Akahoshi T.
The role of diagnostic and therapeutic endoscopic retrograde pancreatography in traumatic pancreatic injury: a retrospective single-center study
Surg Today. 2026 Sep 3. doi: 10.1007/s00595-026-03482-y. Online ahead of print.
Yamamoto M, Ideno N, Nakahusa T, Araki T, Miura S, Utsunomiya T, Shigematsu K, Shimada Y, Yamamoto T, Fujimoto T, Abe T, Watanabe Y, Tamura K, Ikenaga N, Nakata K, Fujimori N, Fujita N, Ohuchida K, Onishi H, Ogawa Y, Ishigami K, Aishima S, Oda Y.
PRSS(1A16V) germline mutation is common in a cohort of intraductal papillary mucinous neoplasms of the pancreas
Surgery. 2026 Oct;198:110451.
Kamata K, Okuda A, Ogura T, Shimokawa Y, Ohno A, Fujimori N, Itonaga M, Kitano M, Matsumoto K, Mandai K, Shiomi H, Sagami R, Imai H, Maruyama H, Kamada H, Takenaka M.
Utility of endoscopic ultrasound-guided hepaticoduodenostomy for intrahepatic bile duct drainage: a multicenter retrospective study in Western Japan
Minim Invasive Ther Allied Technol. 2026 Aug;35(4):276-286.
Komori Y, Hijioka S, Yagi S, Nagashio Y, Harai S, Yamashige D, Onuma K, Fujisaki K, Agarie D, Okamoto K, Fukuda S, Kuwada M, Torres JJ, Ueda K, Fujimori N, Saito Y, Ogawa Y, Okusaka T.
"Vanishing needle tract" in endoscopic ultrasound-guided tissue acquisition: definition, incidence, and risk factors in a large single-center cohort
Gastrointest Endosc. 2026 May 20:S0016-5107(26)06744-1. doi: 10.1016/j.gie.2026.05.009. Online ahead of print.
Matsumoto T, Yamamoto T, Osajima S, Nakanishi Y, Noguchi S, Mizuuchi Y, Murakami M, Ueda K, Takigawa K, Shimo M, Miyawaki K, Kato K, Fujimori N, Nakata K, Aishima S, Oda Y.
p62/SQSTM1 Accumulation Defines an Epithelial-Mesenchymal Transition (EMT)/Twist1-Associated Infiltrative Phenotype in Pancreatic Neuroendocrine Tumors
Mod Pathol. 2026 Jun;39(6):101001.
Hiroshima Y, Sagami R, Kuraoka N, Noguchi T, Matsuda Y, Terayama T, Azuma Y, Sato T, Nishikori H, Honda H, Goto Y, Noguchi H, Fukuchi S, Omori K, Motomura M, Okimoto T, Okamoto K, Mori H, Sato T, Takahashi K, Ozawa E, Ikeda E, Kanno A, Komoto S, Koga T, Ishida Y, Kobayashi K, Hinokuchi M, Ihara R, Ueda T, Fujimori N, Matsunari O, Noguchi C, Mizukami K, Murakami K.
Sphincterotomy during endoscopic biliary drainage in cholangitis with sepsis-induced coagulopathy increases bleeding without clinical benefits
Dig Liver Dis. 2026 Apr;58(4):527-533.
Iwasaki E, Kasashima H, Takada Y, Hara K, Iwai T, Okano N, Kubota K, Yamao T, Yamamoto K, Shiomi H, Ikezawa K, Ushio J, Kato H, Fujimori N, Katanuma A, Ozawa E, Takahara N, Nakahara K, Ueki T, Hashimoto S, Ryozawa S, Isayama H, Irisawa A, Inui K, Fujita N, Kayashima A, Horibe M, Bazerbachi F, Itoi T, WORKING GROUP
Clinical outcomes of endoscopic papillectomy for ampullary adenoma and adenocarcinoma: a multicenter retrospective study in Japan
Gastrointest Endosc. 2026 May;103(5):1016-1027.e5.
Matsukane R, Minami H, Fujimori N, Ueda K, Komori Y, Takamatsu Y, Ueda T, Kimura M, Matsuzaki C, Tanaka T, Morito A, Kuwahara S, Hashimoto M, Hirai S, Yokoyama T, Ishida S, Hirota T, Ogawa Y, Uchida M.
Prospective study of Anamorelin in pancreatic cancer cachexia: clinical and translational insights into response heterogeneity
Clin Nutr. 2026 Mar :58:106581.
Ota S, Shiomi H, Fujii Y, Matsumoto K, Kano M, Shimatani M, Fujita N, Kamada H, Ueno S, Ogura T, Takenaka M, Nagao K, Sakai A, Shintani S, Inatomi O, Kitagawa K, Nakano R, Koizumi M, Imamura Y, Ohno A, Fujimori N, Tamura T, Miyagahara T, Nakajima M, Kitano M.
Effectiveness and Safety of Enteroscopy-Assisted ERP-Guided Versus EUS-Guided Pancreatic Duct Drainage for Pancreaticojejunostomy Strictures: A Multicenter Observational Study
Dig Endosc. 2026 Mar;38(3):e70128.
Okamoto K, Hijioka S, Kobayashi N, Imaoka H, Hara K, Takeuchi S, Fujimori N, Sudo K, Horiguchi S, Takada R, Ono T, Terashima T, Shioji K, Kondo S, Furukawa T, Ueno M, Tsumura H, Tobimatsu K, Doi T, Asama H, Kawaguchi S, Kitano Y, Maeda O, Kobayashi S, Arima S, Unno M, Ohno E, Kawata K, Ashida R, Naganuma A, Murohisa G, Yamada R, Satake H, Kodama Y, Yokota I, Okuyama H, Shimizu S, Morizane C, Ueno M, Nagano H, Furuse J; Japan Oncology Network in Hepatobiliary and Pancreas.
Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N)
J Gastroenterol. 2026 Aug;61(8):1159-1169.*
Sano Y, Kajikawa R, Mizusawa J, Ioka T, Ozaka M, Nakamura S, Ito Y, Furuse J, Kobayashi S, Fukuda H, Okusaka T, Ikeda M, Miwa H, Sasahira N, Nagashima F, Ohkawa K, Yamazaki K, Kanai M, Yamashita T, Hara K, Takayama Y, Komatsu Y, Fujimori N, Hama N, Kamata K, Hisano T, Shimizu S, Tobimatsu K, Maeda S, Ueno M.
Comparison of chemoradiotherapy and gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer: an integrated analysis of two randomized phase II trials (JCOG2408A)
BMC Cancer. 2026 Feb 10;26(1):363.
Murakami M, Fujimori N, Matsumoto K, Ueda K, Nakata K, Nakamura M, Yamamoto T, Oda Y, Ito T, Ogawa Y.
Clinical Implications of Ki-67 Index, Grade and Hormonal Changes in Pancreatic Neuroendocrine Tumors: Insights Into Tumor Heterogeneity Based on Primary and Secondary Lesions
J Hepatobiliary Pancreat Sci. 2026 Feb;33(2):141-150.
Ogura T, Kuroda T, Matsuura T, Kitadai J, Kitagawa K, Itonaga M, Takeshita K, Matsumori T, Emori T, Takenaka M, Imai H, Mandai K, Shintani S, Fujimori N, Shiomi H, Asada M, Sagami R, Maruyama H, Ikeura T, Shimatani M, Nishikiori H, Matsumoto K, Kokubu M, Kamada H, Ishida Y, Hakoda A, Kitano M.
EUS-Guided Versus Percutaneous Transhepatic Drainage of Liver Abscesses: A Multicenter Endohepatology Study in Western Japan (EPIC-LA Study)
Dig Endosc. 2026 Jan;38(1):e70067.
Takahashi K, Ozawa E, Hiroshima Y, Sagami R, Hinokuchi M, Murakami M, Fujimori N, Koga T, Ishida Y, Ayuse T, Miyaaki H.
Effectiveness of maintaining oxygenation of a new high flow nasal cannula for endoscopic retrograde cholangiopancreatography during intravenous anesthesia
Trials. 2026 Jan 13;27(1):119.
Masuda A, Notohara K, Kodama Y, Inoue D, Umemura T, Ikeura T, Kanno A, Iwasaki E, Fujimori N, Seno H, Kikuta K, Nakase H, Uehara T, Abe S, Tsujimae M, Nakamura S, Kawano M, Masamune A.
Clinical manifestations of immunoglobulin G4-related gastrointestinal disease: a nationwide multicenter retrospective study
J Gastroenterol. 2026 Jan;61(1):16-26.
Itonaga M, Ogura T, Takenaka M, Matsumoto K, Shiomi H, Shintani S, Kamada H, Yamashita T, Mandai K, Asada M, Imai H, Takeshita K, Ikeura T, Fujimori N, Kinoshita M, Ikezawa K, Sugimori S, Kitagawa K, Sagami R, Kokubu M, Kuroda T, Nishioka N, Hatamaru K, Minaga K, Wan K, Shimokawa T, Kitano M.
Adverse events of EUS-guided biliary drainage for malignant biliary obstruction: a large multicenter study
J Hepatobiliary Pancreat Sci. 2026 Mar;33(3):228-239.
Komori Y, Hijioka S, Nagashio Y, Harai S, Yamashige D, Onuma K, Fujisaki K, Agarie D, Okamoto K, Yagi S, Fukuda S, Kuwada M, Joshua Josef Torres, Ueda K, Fujimori N, Saito Y, Ogawa Y, Okusaka T.
Efficacy of the Stent-in-Stent Technique as a Rescue Method for Removing Embedded Metallic Biliary Stents
DEN Open. 2025 Dec 17;6(1):e70246.
Matsumoto R, Kikuta K, Takikawa T, Nakai Y, Takenaka M, Oki K, Ohno E, Ito K, Fujimori N, Katanuma A, Masuda A, Hori Y, Ikeura T, Suzuki R, Yamamoto S, Sogame Y, Kawashima H, Ito T, Okuwaki K, Itoi T, Takayama Y, Nakamura A, Terai S, Matsumoto K, Kuwatani M, Kishiwada M, Shigekawa M, Matsumori T, Inatomi O, Hatta W, Irisawa A, Unno M, Takeyama Y, Masamune A, Japan Pancreatitis Study Group for Chronic Pancreatitis
Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer
J Gastroenterol. 2026 Jan; 61(1): 105-116.
Ohno A, Fujimori N, Matsumoto K, Haji S, Sugahara O, Takeno A, Yamamoto T, Suenaga A, Kakehashi S, Ueda T, Murakami M, Teramatsu K, Ueda K, Oono T, Oda Y, Nakayama KI, Ogawa Y.
Role of the transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma
Oncogene. 2026 Jan; 45(2): 307-321.
Itonaga M, Takenaka M, Ikezawa K, Ikeura T, Shimatani M, Asada M, Fujimori N, Sagami R, Ogura T, Imai H, Matsumoto K, Shintani S, Shiomi H, Hatamaru K, Minaga K, Takada R, Wan K, Shimokawa T, Kitano M.
Balloon Enteroscopy-Assisted ERCP Versus Endoscopic Ultrasound-Guided Biliary Drainage for Unresectable Malignant Biliary Obstruction in Patients With Surgically Altered Anatomy: A Multicenter Prospective Registration Study
Dig Endosc. 2025 Nov;37(11):1179-1189.
Ohba A, Ozaka M, Mizusawa J, Okusaka T, Kobayashi S, Yamashita T, Ikeda M, Yasuda I, Sugimori K, Sasahira N, Ikezawa K, Miki I, Okano N, Mizuno N, Furukawa M, Shirakawa H, Sano Y, Katayama H, Furuse J, Ueno M; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial
J Clin Oncol. 2025 Nov;43(31):3345-3354.
Murakami M, Fujimori N, Suenaga A, Ueda T, Kakehashi S, Furuta A, Ohno A, Matsumoto K, Takamatsu Y, Ueda K, Ogawa Y.
Efficacy and Safety of Duodenal Stenting for Malignant Gastric Outlet Obstruction: Insights From a 15-year Single-Center Experience
DEN Open. 2025 Aug 25;6(1):e70192.
Ogura T, Tanisaka Y, Sekine M, Kobayashi K, Maruyama H, Hirai S, Shiomi H, Shigekawa M, Kuwatani M, Ikezawa K, Itonaga M, Takenaka M, Hijioka S, Ikeura T, Doi S, Fujimori N, Koizumi K, Nakai Y, Inoue T, Mukai S, Matsumoto K, Minami R, Mandai K, Matsuda A, Iwashita T, Kawashima H, Itoi T.
Japanese Multi-Institution Study of Success Rates of Wire-Guided Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography in Relation to Guidewire tip Length (With Video)
DEN Open. 2025 Jun 16;6(1):e70144.
Minoda Y, Suzuki Y, Ogino H, Nagatomo S, Xiaopeng Bai, Esaki M, Wada M, Tanaka Y, Hata Y, Fujimori N, Umekita S, Tsurumaru D, Ota M, Oki E, Ihara E, Ogawa Y.
Traction-assisted endoscopic ultrasound-guided fine-needle biopsy using the clip-with-thread method for small gastric subepithelial lesions: Randomized controlled trial (with video)
Dig Endosc. 2025 May;37(5):512-520.
Hirano H, Hirata K, Honma Y, Morizane C, Machida N, Kato K, Okusaka T, Boku N, Sekine S, Hiraoka N, Mizusawa J, Sano Y, Shibuya Y, Takahashi M, Fujimori N, Nomura M, Doki Y, Ueno M, Yoshikawa T, Takeuchi H.
Prognostic factors for overall survival in advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: a post hoc analysis of JCOG1213.
ESMO Gastrointest Oncol. 2025 May 16:8:100178.
Koga T, Ishida Y, Hashigo S, Shimokawa Y, Harima H, Okamoto K, Ohno A, Miyagahara T, Fujita T, Fukuchi S, Takahashi K, Taguchi H, Araki N, Ohtsuka Y, Uekitani T, Tsuneyoshi K, Akiyama T, Ishigaki N, Maruo T, Saito H, Ihara R, Yamasuji A, Oe S, Yoshinari M, Sagami R, Fujimori N, Fukuda Y, Ozawa E, Jikuya K, Shinohara H, Sen-Yo M, Ueki T, Tsuchiya N, Kitaguchi T, Matsumoto K, Fukuyama M, Hirai F.
Feasibility and safety of EUS-guided biliary drainage in inexperienced centers: a multicenter study in southwest Japan
Gastrointest Endosc. 2025 Apr;101(4):843-852.e2.
Takeshita K, Hijioka S, Ikezawa K, Ogura T, Kuwatani M, Fujimori N, Doi S, Endo M, Matsubara S, Yamada R, Mashima H, Kataoka M, Takada R, Okuda A, Ohno A, Katsukura N, Suzuki H, Tanaka T, Sekine M, Kitamura H, Okusaka.
Uncovered Self Expandable Metallic Stent with an Ultra Thin Delivery Sheath in Unresectable Malignant Hilar Biliary Obstruction: A Multicenter Prospective Observational Study
Dig Dis Sci. 2025 Apr;70(4):1560-1572.
Oyama K, Nakata K, Abe T, Hirotaka K, Fujimori N, Kiyotani K, Iwamoto C, Ikenaga N, Morisaki S, Umebayashi M, Tanaka H, Koya N, Nakagawa S, Tsujimura K, Yoshimura S, Onishi H, Nakamura Y, Nakamura M and Morisaki T.
Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study
Frontiers in Immunology. 2025 Apr 3:16:1571182
Shibuki T, Ikeda M, Yokoyama M, Sano Y, Furuse J, Kobayashi S, Ohba A, Todaka A, Horie T, Shoji K, Kanai M, Nishina T, Kumamoto Y, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Miwa H, Ozaka M, Ueno M.
Depth of response in patients with locally advanced pancreatic cancer treated with first-line chemotherapy: a supplementary analysis of JCOG1407
Pancreatology. 2025 Mar;25(2):275-283.
Ikeura T, Takaori A, Kikuta K, Ito K, Takikawa T, Eguchi T, Inoue T, Hori Y, Nakamura K,
Takenaka M, Sogame Y, Takagi T, Fujimori N, Yamamoto S, Nakamura A, Sakai T, Sakai A, Tamura T, Saito T, Fujita K, Kanno A, Hosono K, Iwata K, Irisawa A, Okamoto K, Kuwatani M, Naganuma M, Masamune A and Takeyama Y, Japan Pancreatitis Study Group for CP
Complete clearance of painless pancreatic stones with endotherapy prevents the progression of pancreatic parenchyma atrophy in patients with chronic pancreatitis: Multicenter cohort study
Dig Endosc. 2025 Jun;37(6): 638-650.
Takeshita K, Hijioka S, Ikezawa K, Ogura T, Kuwatani M, Fujimori N, Doi S, Endo M, Matsubara S, Yamada R, Mashima H, Kataoka M, Takada R, Okuda A, Ohno A, Katsukura N, Suzuki H, Tanaka T, Sekine M, Kitamura H, Okusaka.
Uncovered Self‑Expandable Metallic Stent with an Ultra‑Thin Delivery Sheath in Unresectable Malignant Hilar Biliary Obstruction: A Multicenter Prospective Observational Study
Dig Dis Sci. 2025 Apr;70(4):1560-1572.
Fujimori N, Fujita N, Murakami M, Ohno A, Matsumoto K, Teramatsu K, Ueda K, Wada N, Takao S, Okamoto D, Ishigami K, Ito T, Ogawa Y.
Usefulness of semi-automated 3D volumetric assessment of liver tumor burden for patients with unresectable pancreatic neuroendocrine tumor: A pilot study
Pancreas. 2025 Feb 1;54(2):e122-e129.
Ikenaga N, Nakata K, Abe T, Watanabe Y, Ideno N, Murakami M, Ueda K, Fujimori N, Fujita N, Ishigami K, Ogawa Y, Nakamura M.
Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma
Surgery. 2025 Feb:178:108958.
Sano T, Kikuta K, Takikawa T, Matsumoto R, Okazaki K, Takeyama Y, Masamune A; Japan Pancreatitis Study Group for AIP (JPSG-AIP).
Serum IgG4-negative and IgG4-positive type 1 autoimmune pancreatitis present with different clinicopathological features: An analysis of a nationwide survey in Japan
Pancreatology. 2025 Feb;25(1):82-88.
Ohno A, Fujimori N, Kaku T, Matsumoto K, Murakami M, Teramatsu K, Ueda K, Hijioka M, Aso A, Ogawa Y.
Puncture angle on an endoscopic ultrasound image is independently associated with unsuccessful guidewire maniqulation of endscopic ultrasound-guided hepaticogastrostomy: a retrospective study in Japan.
Clin Endosc. 2024 Sep;57(5):656-665.
Ohno A, Fujimori N, Kaku T, Shimokawa Y, Miyagahara T, Suehiro Y, Gerodias A, Kakehashi S, Matsumoto K, Murakami M, Ueda K, Ogawa Y.
Feasibility of Endoscopic Ultrasound-Guided Hepaticogastrostomy for Malignant Hilar Biliary Obstruction
Dig Dis Sci. 2025 Jan;70(1):419-428.
Saito T, Takenaka M, Kuwatani M, Doi S, Ohyama H, Fujisawa T, Masuda A, Iwashita T, Shiomi H, Hayashi N, Iwata K, Maruta A, Mukai T, Matsubara S, Hamada T, Inoue T, Matsumoto K, Hirose S, Fujimori N, Kashiwabara K, Kamada H, Hashimoto S, Shiratori T, Yamada R, Kogure H, Nakahara K, Ogura T, Kitano M, Yasuda I, Isayama H, Nakai Y; WONDERFUL study group in Japan and collaborators.
WONDER-02: plastic stent vs. lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic pseudocysts-study protocol for a multicentre randomised non-inferiority trial.
Trials. 2024 Aug 24;25(1):559.
Ogura T, Ishiwatari H, Hijioka S, Takeshita K, Sato J, Takenaka M, Fukunaga T, Omoto S, Fujimori N, Ohno A, Hatamaru K, Tamura T, Imai H, Yamada M, Hakoda A, Nishikawa H, Kitano M.
Multicenter study comparing EUS-guided hepaticogastrostomy and ERCP for malignant biliary obstruction in patients with accessible papillae
J Hepatobiliary Pancreat Sci. 2024 Sep;31(9):680-687.
Ishiwatari H, Kawabara T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H, Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Endoscopic nasobiliary drainage versus endoscopic biliary stenting for preoperative biliary drainage in patients with malignant hilar biliary obstruction: A propensity score matched multicenter comparative study
Dig Endosc. 2024 Jun;36(6):726-734.
Koga T, Ishida Y, Hashigo S, Shimokawa Y, Harima H, Okamoto K, Ohno A, Miyagahara T, Fujita T, Fukuchi S, Takahashi K, Taguchi H, Araki N, Ohtsuka Y, Uekitani T, Tsuneyoshi K, Akiyama T, Ishigaki N, Maruo T, Saito H, Ihara R, Yamasuji A, Oe S, Yoshinari M, Sagami R, Fujimori N, Fukuda Y, Ozawa E, Jikuya K, Shinohara H, Sen-Yo M, Ueki T, Tsuchiya N, Kitaguchi T, Matsumoto K, Fukuyama M, Hirai F.
Feasibility and safety of endoscopic ultrasound-guided biliary drainage in inexperienced centers: a multicenter study in Southwest Japan.
Gastrointest Endosc. 2024 Sep 13:S0016-5107(24)03495-3.
Matsumoto K, Fujimori N, Ichihara K, Takeno A, Murakami M, Ohno A, Kakehashi S, Teramatsu K, Ueda K, Nakata K, Sugahara O, Yamamoto T, Matsumoto A, Nakayama KI, Oda Y, Nakamura M, Ogawa Y.
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction.
J Gastroenterol. 2024 Jul;59(7):629-640.
Murakami M, Fujimori N, Takamatsu Y, Ito T, Matsumoto K, Kakehashi S, Ohno A, Teramatsu K, Ueda K, Ishigami K and Ogawa Y.
Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice
Jpn J Clin Oncol. 2024 Jun 1;54(6):647-657.
Takikawa T, Kikuta K, Sano T, Ikeura T, Fujimori N, Umemura T, Naitoh I, Nakase H, Isayama H, Kanno A, Kamata K, Kodama Y, Inoue D, Ido A, Ueki T, Seno H, Yasuda H, Iwasaki E, Nishino T, Kubota K, Arizumi T, Tanaka A, Uchida K, Matsumoto R, Hamada S, Nakamura S, Okazaki K, Takeyama Y, Masamune A; Japan Pancreatitis Study Group for AIP.
Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan
Pancreatology. 2024 May;24(3):335-342.
Shibata K, Fujimori N, Oono T, Motooka D, Okuzaki D, Sonoda K, Ogawa Y, Yamasaki S.
Single-cell analysis for identification of T-cell clonotypes associated with IgG4 production of autoimmune pancreatitis.
Gastroenterol Rep (Oxf). 2023 Dec 8:11:goad071.
Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y.
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
J Gastroenterol. 2023 Jun;58(6):586-597.
Miyagahara T, Fujimori N, Ueda K, Takamatsu Y, Matsumoto K, Teramastu K, Takaoka T, Suehiro Y, Shimokawa Y, Omori K, Niina Y, Tachibana Y, Akashi T, Oono T, Ogawa Y.
Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Asia Pac J Clin Oncol. 2023 Aug;19(4):533-541.
Mizuno N, Ioka T, Ogawa G, Nakamura S, Hiraoka N, Ito Y, Katayama S, Takada R, Kobayashi S, Ikeda M, Muwa H, Okano N, Kuramochi H, Sekimoto M, Okusaka T, Ozaka M, Todaka A, Gotoh K, Tobimatsu K, Yamaguchi H, Nakagohri T, Kajiura S, Sudo K, Okamura K, Shimizu S, Shirakawa H, Kato N, Sano K, Iwai T, Fujimori N, Ueno M, Ishii H, Furuse J and Hepatobiliary and Pancreatic Oncology Group (HBPOG) of Japan Clinical Oncology Group (JCOG)
Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106
Jpn J Clin Oncol. 2023 Jul 31;53(8):704-713.
Fujita N, Ushijima Y, Itoyama M, Okamoto D, Ishimatsu K, Wada N, Takao S, Murayama R, Fujimori N, Nakata K, Nakamura M, Yamamoto T, Oda Y, Ishigami K.
Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy of preoperative neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma.
Eur J Radiol. 2023 May; 162:110756.
Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG).
A randomized phase Ⅱ study of modified FOLFIRINOX versus gemcitabine plusnab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Eur J Cancer. 2023 Mar;181:135-144.
Ikenaga N, Nakata K, Abe T, Ideno N, Fujimori N, Oono T, Fujita N, Ishigami K, Nakamura M.
Risks and benefits of pancreaticoduodenectomy in patients aged 80 years and over
Langenbecks Arch Surg. 2023 Feb 27;408(1):108.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J, Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
Lancet. 2023 Jan 21;401(10372):195-203.
Ikenaga N, Nakata K, Hayashi M, Nakamura S, Abe T, Ideno N, Murakami M, Fujimori N, Fujita N, Isoda T, Baba S, Ishigami K, Oda Y, Nakamura M.
Clinical Implications of FDG PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy
J Gastrointest Surg. 2023 Feb;27(2):337-346.
Ohno A, Fujimori N, Kaku T, Takamatsu Y, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Hijioka M, Kawabe K, Harada N, Nakamuta M, Aso A, Oono T, Ogawa Y.
Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
Dig Dis Sci. 2022 Dec;67(12):5676-5684.
Minaga K, Kitano M, Uenoyama Y, Hatamaru K, Shiomi H, Ikezawa K, Miyagahara T, Imai H, Fujimori N, Matsumoto H, Shimokawa Y, Masuda A, Takenaka M, Kudo M, Chiba Y.
Feasibility and efficacy of endoscopic reintervention after covered metal stent placement for EUS-guided hepaticogastrostomy: A multicenter experience.
Endosc Ultrasound. 2022 Nov-Dec;11(6):478-486.
Shibata K. Motozono C, Nagae M, Shimizu T, Ishikawa E, Motooka D, Okuzaki D, Izumi Y, Takahashi M, Fujimori N, Wing JB, Hayano T, Asai Y, Bamba T, Ogawa Y, Furutani-Seiki Makoto, Shirai M, Yamasaki S.
Symbiotic bacteria-dependent expansion of MR1-reactive T cells causes autoimmunity in the absence of Bcl11b
Nat Commun. 2022 Nov 14;13(1):6948.
Teramatsu K, Oono T, Oyama K, Fujimori N, Murakami M, Yasumori S, Ohno A, Matsumoto K, Takeno A, Nakata K, Nakamura M, Ogawa Y.
Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
BMC Cancer. 2022 Nov 4;22(1):1134.
Ohno A, Fujimori N, Kaku T, Hijioka M, Kawabe K, Harada N, Nakamuta M, Oono T, Ogawa Y.
The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center.
Clin Endosc. 2022 Nov;55(6):784-792.
Minoda Y, Esaki M, Ihara E, Nagatomo S, Nishioka K, Fujimori N, Ogino H, Bai X, Tanaka Y, Chinen T, Hu Q, Ota M, Umekita S, Yamamoto H, Ogawa Y.
Auxiliary diagnosis of subepithelial lesions by impedance measurement during endoscopic ultrasound guided fine-needle biopsy.
Gastrointest Endosc. 2023 May;97(5):977-984.
Shimizu K, Ito T, Irisawa A, Ohtsuka T, Ohara H, Kanno A, Kida M, Sakagami J, Sata N, Takeyama Y, Tahara J, Hirota M, Fujimori N, Masamune A, Mochida S, Enomoto N, Shimosegawa T, Koike K.
Evidence-based clinical practice guidelines for chronic pancreatitis 2021.
J Gastroenterol. 2022 Oct;57(10):709-724.
Kubota K, Oguchi T, Fujimori N, Yamada K, Naitoh I, Okabe Y, Iwasaki E, Masamune A, Ikeura T, Kamisawa T, Inoue D, Kumagi T, Ogura T, Kodama Y, Katanuma A, Hirano K, Inui K, Isayama H, Sakagami J, Nishino T, Kanno A, Kurita Y, Okazaki K, Nakamura S.
Steroid therapy has an acceptable role as the initial treatment in autoimmune pancreatitis patients with pancreatic cyst formation: based on a Japanese nationwide study. Collaborators.
J Hepatobiliary Pancreat Sci. 2023 May;30(5):664-677.
Ishiwatari H, Kawabata T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H, Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction.
Dig Dis Sci. 2023 Apr;68(4):1139-1147.
Minoda Y, Ihara E, Fujimori N, Nagatomo S, Esaki M, Hata Y, Bai X, Tanaka Y, Ogino H, Chinen T, Hu Q, Oki E, Yamamoto H, Ogawa Y.
Efficacy of ultrasound endoscopy with artificial intelligence for the differential diagnosis of non-gastric gastrointestinal stromal tumors.
Sci Rep 2022 Oct 5;12(1):16640.
Miki M, Fujimori N, Ueda K, Lee L, Murakami M, Takamatsu Y, Shimokawa Y, Niina Y, Oono T, Hisano T, Furukawa M, Ogawa Y.
Treatment effect and safety of nanoliposomal irinotecan with fluorouracil and folinic acid after gemcitabine-based therapy in patients with advanced pancreatic cancer: A multicenter, prospective observational study.
J Clin Med. 2022 Aug 30;11(17):5084.
Morizane C, Machida N, Honma Y, Okusaka T, Boku N, Kato K, Nomura S, Hiraoka N, Sekine S, Taniguchi H, Okano N, Yamaguchi K, Sato T, Ikeda M, Mizuno N, Ozaka M, Kataoka T, Ueno M, Kitagawa Y, Terashima M, Furuse J; Japan Clinical Oncology Group (JCOG).
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial
JAMA Oncol. 2022 Oct 1;8(10):1447-1455.
Minoda Y, Ihara E, Itaba S, Sumida Y, Haraguchi K, Aso A, Mizutani T, Osoegawa T, Esaki M, Nagatomo S, Nishioka K, Muta K, Bai X, Ogino H, Fujimori N, Tsurumaru D, Ohuchida K, Qingjiang H, Oki E, Yamamoto H, Ogawa Y.
Negligible procedure-related dissemination risk of mucosal incision-assisted biopsy for gastrointestinal stromal tumors versus endoscopic ultrasound-guided fine-needle aspiration/biopsy.
Surg Endosc. 2023 Jan;37(1):101-108.
Takamatsu Y, Fujimori N, Miyagahara T, Suehiro Y, Kaku T, Kawabe K, Ohno A, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Oono T, Ogawa Y.
The Glasgow Prognostic Score and stricture site can predict prognosis after endoscopic duodenal stent placement for malignant gastric outlet obstruction.
Sci Rep. 2022 Jun 13;12(1):9746.
Murakami M, Fujimori N, Matsumoto K, Ohno A, Teramatsu K, Takamatsu Y, Takeno A, Ueda K, Oono T, Ito T, Ogawa Y.
A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a singlecenter experience.
Endocr J. 2022 Oct 28;69(10):1201-1209.
Matsumoto K, Fujimori N, Hata Y, Minoda Y, Murakami M, Teramatsu K, Takamatsu Y, Takeno A, Oono T, Ihara E, Nakata K, Nakamura M, Yamamoto T, Koga Y, Oda Y, Ito T, Ogawa Y.
Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
Dig Dis. 2023;41(2):316-324.
Kitano M, Yoshida M, Ashida R, Kita E, Katanuma A, Itoi T, Mikata R, Nishikawa K, Matsubayashi H, Takayama Y, Kato H, Takenaka M, Ueki T, Kawashima Y, Nakai Y, Hashimoto S, Shigekawa M, Nebiki H, Tsumura H, Okabe Y, Ryozawa S, Harada Y, Mitoro A, Sasaki T, Yasuda H, Miura N, Ikemoto T, Ozawa E, Shioji K, Yamaguchi A, Okuzono T, Moriyama I, Hisai H, Fujita K, Goto T, Shirahata N, Iwata Y, Okabe Y, Hara K, Hashimoto Y, Kuwatani M, Isayama H, Fujimori N, Masamune A, Hatamaru K, Shimokawa T, Okazaki K, Takeyama Y, Yamaue H; Committee of Clinical Research, Japan Pancreas Society.
Needle tract seeding after endoscopic ultrasound-guided tissue acquisition of pancreatic tumors: A nationwide survey in Japan.
Dig Endosc. 2022 Nov;34(7):1442-1455.
Ogura T, Ishiwatari H, Fujimori N, Iwasaki E, Ishikawa K, Satoh T, Kaneko J, Sato J, Oono T, Matsumoto K, Fukuhara S, Kayashima A, Hakoda A, Higuchi K.
Propensity score matching analysis for adverse events of EUS-guided biliary drainage in advanced elderly patients (PEACE study).
Therap Adv Gastroenterol. 2022 May 17;15:17562848221092612.
Murakami M, Fujimori N, Ohno A, Matsumoto K, Teramatsu K, Takamatsu Y, Takeno A, OonoT, Abe T, Ideno N, Ikenaga N, Nakata K, Nakamura M, Ishigami K, Ogawa Y.
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: A single-center retrospective study
Discov Oncol. 2022 Jan 3;13(1):2.
Fujimori N, Minoda Y, Ogawa Y.
What is the best modality for diagnosing pancreatic cancer?
Dig Endosc. 2022 34:744-746.
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
J Gastroenterol. 2021 Nov;56(11):1033-1044.
Ito T, Fujimori N, Honma Y, Kudo A, Hijioka S, Katsushima S, Kimura Y, Fukutomi A, Hisamatsu S, Nakajima A, Shimatsu A.
Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study.
Asia Pac J Clin Oncol. 2021 Oct;17(5):e153-e161.
Okuno H, Ogino H, Ihara E, Nishioka K, Tanaka Y, Chinen T, Kohjima M, Oono T, Tanaka M, Goya T, Fujimori N, Iboshi Y, Gotoda T, Ogawa Y.
Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified
BMC Gastroenterol. 2021 Feb 16;21(1):73.
Fujimori N, Osoegawa T, Aso A, Itaba S, Minoda Y, Murakami M, Matsumoto K, Teramatsu K, Takamatsu Y, Takaoka T, Oono T, Ihara E, Yoshizumi T, Ohtsuka T, Nakamura M, Ogawa Y.
Efficacy of early endoscopic ultrasound-guided transluminal drainage for postoperative pancreatic fistula
Can J Gastroenterol Hepatol. 2021 Jan 25:6691705.
Masamune A, Kikuta K, Kume K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K, Japan Pancreas Society
Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019.
J Gastroenterol. 2020 Nov;55(11):1062-1071.
Minaga K, Takenaka M, Ogura T, Tamura T, Kuroda T, Kaku T, Uenoyama Y, Noguchi C, Nishikiori H, Imai H, Sagami R, Fujimori N, Higuchi K, Kudo M, Chiba Y, Kitano M.
Endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction with surgically altered anatomy: a multicenter prospective registration study
Therap Adv Gastroenterol. 2020 Jul 29;13:1756284820930964.
Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Japan Pancreas Society.
Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016.
Pancreatology. 2020 Jun;20(4):629-636.
Fujimori N, Miki M, Lee L, Matsumoto K, Takamatsu Y, Takaoka T, Teramatsu K, Suehiro Y, Murakami M, Igarashi H, Oono T, Ohtsuka T, Nakamura M, Koga Y, Oda Y, Ito T, Ogawa Y.
Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years.
Pancreatology. 2020 Jun;20(4):709-715.
Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Collaborators.
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.
J Gastroenterol. 2020 Apr;55(4):462-470.
Fujita N, Nishie A, Asayama Y, Ishigami K, Fujimori N, Ito T, Honda H
Intravoxel incoherent motion magnetic resonance imaging for assessment of chronic pancreatitis with special focus on its early stage.
Acta Radiol. 2020 May;61(5):579-585.
Miki M, Oono T, Fujimori N, Takaoka T, Kawabe K, Miyasaka Y, Ohtsuka T, Saito D, Nakamura M, Ohkawa Y, Oda Y, Suyama M, Ito T, Ogawa Y.
CLEC3A, MMP7, and LCN2 as Novel Markers for Predicting Recurrence in Resected G1 and G2 Pancreatic Neuroendocrine Tumors.
Cancer Med. 2019 Jul;8(8):3748-3760.
Miyasaka Y, Ohtsuka T, Kimura R, Matsuda R, Mori Y, Nakata K, Kakihara D, Fujimori N, Ohno T, Oda Y, Nakamura M.
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery.
Ann Surg Oncol. 2019 May;26(5):1528-1534.
Miki M, Fujimori N, Oono T, Kawabe K, Ohno A, Matsumoto K, Teramatsu K, Tachibana Y, Ogawa Y.
Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.
J Dig Dis. 2019 Mar;20(3):152-158.
Toriyama K, Hijioka S, Komoto I, Kobayashi N, Okusaka T, Ku Y, Sudo K, Furukawa M, Tachibana Y, Takahashi M, Yasuda H, Nakamori S, Honma Y, Kida M, Fujimori N, Kashiwada T, Masui T, Ishii H, Tsuchiya Y, Isaji S, Mizuno N, Hara K, Sakamine M, Imamura M, Kagimura T, Ito T.
Study Protocol for Prospective Observational Study 1 on the Prognosis of Patients with Unresectable Advanced Gastrointestinal and Pancreatic Neuroendocrine Tumors (PROP-UP 1 Study) in Japan.
J Clin Trials Vol 8(4) 2018.
Ohtsuka T, Gotoh Y, Nakashima Y, Okayama Y, Nakamura S, Morita M, Aly MYF, Velasquez VVDM, Mori Y, Sadakari Y, Nakata K, Miyasaka Y, Ishigami K, Fujimori N, Mochidome N, Oda Y, Shimizu S, Nakamura M.
Role of SpyGlass-DStm in the preoperative assessment of pancreatic intraductal papillary mucinous neoplasm involving the main pancreatic duct.
Pancreatology 2018 Jul;18(5):566-571.
Yasunaga K, Ito T, Miki M, Ueda K, Fujiyama T, Tachibana Y, Fujimori N, Kawabe K, Ogawa Y.
Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells.
Biomed Res Int 2018 May 17:2018:8719397.
L Lee , Ito T, Igarashi H, Miki M, Fujimori N, Kawabe K, Jensen RT, Ogawa Y.
Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors.
Cancer Chemother Pharmacol. 81:163-169, 2018.
Ueda K, Kawabe K, Lee L, Tachibana Y, Fujimori N, Igarashi H, Oda Y, Jensen RT, Takayanagi R, Ito T.
Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.
Pancreas. 46:476-481, 2017.
Niina Y, Ito T, Ueda K, Lee L, Igarashi H, Hijioka M, Takaoka T, Fujiyama T, Miki M, Tachibana Y, Fujimori N, Ohtsuka T, Nakamura K, Kawabe K, Ogawa Y.
Effectiveness of endoscopic duodenal stenting for the management of patients with unresectable pancreatic cancer.
Gastroenterol Hepatol Endosc, 2: 1-5, 2017.
Fujimori N, Osoegawa T, Lee L, Tachibana Y, Aso A, Kubo H, Kawabe K, Igarashi H, Nakamura K, Oda Y, Ito T.
Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
Scand J Gastroenterol 51: 245-252, 2016.
Lee L, Igarashi H, Fujimori N, Hijioka M, Kawabe K, Oda Y, Jensen RT, Ito T.
Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine tumors:a single-center retrospective study.
Jpn J Clin Oncol 45: 1131-1138, 2015.
Kohjima M, Yoshimoto T, Enjoji M, Fukushima N, Fukuizumi K, Nakamura T, Kurokawa M, Fujimori N, Sasaki Y, Shimonaka Y, Murata Y, Koyama S, Kawabe K, Haraguchi K, Sumida Y, Harada N, Kato M, Kotoh K, Nakamuta M.
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
World J Gastroenterol. 21:3291-9, 2015.
Hijioka M, Ito T, Igarashi H, Fujimori N, Lee L, Nakamura T, Jensen RT, Takayanagi R.
Serum Chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumor.
Cancer Sci 105: 1464-1471, 2014.
Niina Y, Ito T, Oono T, Nakamura T, Fujimori N, Igarashi H, Sakai Y, Takayanagi R.
A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
Pancreatology. 14:201-10. 2014.
Fujimori N, Igarashi H, Asou A, Kawabe K, Lee L, Oono T, Nakamura T, Niina Y, Hijioka M, Uchida M, Kotoh K, Nakamura K, Ito T, Takayanagi R.
Endoscopic approach through the minor papilla in the management of pancreatic diseases.
World J Gastrointest Endosc 5: 81-88, 2013.
Uchida M, Ito T, Nakamura T, Igarashi H, Oono T, Fujimori N, Kawabe K, Suzuki K, Jensen RT, Takayanagi R.
ERK pathway and sheddases play an essential role in ethanol-induced CX3CL1 release in pancreatic stellate cells.
Lab Invest.93:41-53. 2013.
Nakamura T, Ito T, Igarashi H, Uchida M, Hijioka M, Oono T, Fujimori N, Niina Y, Suzuki K, Jensen RT, Takayanagi R.
Cytosolic double-stranded DNA as a damage-associated molecular pattern induces the inflammatory response in rat pancreatic stellate cells: a plausible mechanism for tissue injury-associated pancreatitis.
Int J Inflam.2:504128.2012.
Igarashi H, Ito T, Oono T, Nakamura T, Fujimori N, Niina Y, Hijioka M, Uchida M, Lee R, Iwao R, Nakamura K, Kotoh K, Takayanagi R.
Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases.
J Dig Dis.13:274-9, 2012.
Fujimori N, Oono T, Igarashi H, Ito T, Nakamura T, Uchida M, Coy DH, Jensen RT, Takayanagi R.
Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase.
Peptides. 32:2067-76, 2011.
Nakamura T, Ito T, Oono T, Igarashi H, Fujimori N, Uchida M, Niina Y, Yasuda M, Suzuki K, Takayanagi R.
Bacterial DNA promotes proliferation of rat pancreatic stellate cells thorough toll-like receptor 9: potential mechanisms for bacterially induced fibrosis.
Pancreas. 40:823-31, 2011.
Ito T, Nakamura T, Fujimori N, Niina Y, Igarashi H, Oono T, Uchida M, Kawabe K, Takayanagi R, Nishimori I, Otsuki M, Shimosegawa T.
Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.
J Dig Dis. 12:210-6, 2011.
Ito T, Otsuki M, Igarashi H, Kihara Y, Kawabe K, Nakamura T, Fujimori N, Oono T, Takayanagi R, Shimosegawa T.
Epidemiological Study of Pancreatic Diabetes in Japan in 2005: A Nationwide Study.
Pancreas. 39:829-835, 2010.
Gibo J, Ito T, Kawabe K, Hisano T, Inoue M, Fujimori N, Oono T, Arita Y and Nawata H.
Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.
Lab Invest. 85:75-89, 2005.
The role of diagnostic and therapeutic endoscopic retrograde pancreatography in traumatic pancreatic injury: a retrospective single-center study
Surg Today. 2026 Sep 3. doi: 10.1007/s00595-026-03482-y. Online ahead of print.
Yamamoto M, Ideno N, Nakahusa T, Araki T, Miura S, Utsunomiya T, Shigematsu K, Shimada Y, Yamamoto T, Fujimoto T, Abe T, Watanabe Y, Tamura K, Ikenaga N, Nakata K, Fujimori N, Fujita N, Ohuchida K, Onishi H, Ogawa Y, Ishigami K, Aishima S, Oda Y.
PRSS(1A16V) germline mutation is common in a cohort of intraductal papillary mucinous neoplasms of the pancreas
Surgery. 2026 Oct;198:110451.
Kamata K, Okuda A, Ogura T, Shimokawa Y, Ohno A, Fujimori N, Itonaga M, Kitano M, Matsumoto K, Mandai K, Shiomi H, Sagami R, Imai H, Maruyama H, Kamada H, Takenaka M.
Utility of endoscopic ultrasound-guided hepaticoduodenostomy for intrahepatic bile duct drainage: a multicenter retrospective study in Western Japan
Minim Invasive Ther Allied Technol. 2026 Aug;35(4):276-286.
Komori Y, Hijioka S, Yagi S, Nagashio Y, Harai S, Yamashige D, Onuma K, Fujisaki K, Agarie D, Okamoto K, Fukuda S, Kuwada M, Torres JJ, Ueda K, Fujimori N, Saito Y, Ogawa Y, Okusaka T.
"Vanishing needle tract" in endoscopic ultrasound-guided tissue acquisition: definition, incidence, and risk factors in a large single-center cohort
Gastrointest Endosc. 2026 May 20:S0016-5107(26)06744-1. doi: 10.1016/j.gie.2026.05.009. Online ahead of print.
Matsumoto T, Yamamoto T, Osajima S, Nakanishi Y, Noguchi S, Mizuuchi Y, Murakami M, Ueda K, Takigawa K, Shimo M, Miyawaki K, Kato K, Fujimori N, Nakata K, Aishima S, Oda Y.
p62/SQSTM1 Accumulation Defines an Epithelial-Mesenchymal Transition (EMT)/Twist1-Associated Infiltrative Phenotype in Pancreatic Neuroendocrine Tumors
Mod Pathol. 2026 Jun;39(6):101001.
Hiroshima Y, Sagami R, Kuraoka N, Noguchi T, Matsuda Y, Terayama T, Azuma Y, Sato T, Nishikori H, Honda H, Goto Y, Noguchi H, Fukuchi S, Omori K, Motomura M, Okimoto T, Okamoto K, Mori H, Sato T, Takahashi K, Ozawa E, Ikeda E, Kanno A, Komoto S, Koga T, Ishida Y, Kobayashi K, Hinokuchi M, Ihara R, Ueda T, Fujimori N, Matsunari O, Noguchi C, Mizukami K, Murakami K.
Sphincterotomy during endoscopic biliary drainage in cholangitis with sepsis-induced coagulopathy increases bleeding without clinical benefits
Dig Liver Dis. 2026 Apr;58(4):527-533.
Iwasaki E, Kasashima H, Takada Y, Hara K, Iwai T, Okano N, Kubota K, Yamao T, Yamamoto K, Shiomi H, Ikezawa K, Ushio J, Kato H, Fujimori N, Katanuma A, Ozawa E, Takahara N, Nakahara K, Ueki T, Hashimoto S, Ryozawa S, Isayama H, Irisawa A, Inui K, Fujita N, Kayashima A, Horibe M, Bazerbachi F, Itoi T, WORKING GROUP
Clinical outcomes of endoscopic papillectomy for ampullary adenoma and adenocarcinoma: a multicenter retrospective study in Japan
Gastrointest Endosc. 2026 May;103(5):1016-1027.e5.
Matsukane R, Minami H, Fujimori N, Ueda K, Komori Y, Takamatsu Y, Ueda T, Kimura M, Matsuzaki C, Tanaka T, Morito A, Kuwahara S, Hashimoto M, Hirai S, Yokoyama T, Ishida S, Hirota T, Ogawa Y, Uchida M.
Prospective study of Anamorelin in pancreatic cancer cachexia: clinical and translational insights into response heterogeneity
Clin Nutr. 2026 Mar :58:106581.
Ota S, Shiomi H, Fujii Y, Matsumoto K, Kano M, Shimatani M, Fujita N, Kamada H, Ueno S, Ogura T, Takenaka M, Nagao K, Sakai A, Shintani S, Inatomi O, Kitagawa K, Nakano R, Koizumi M, Imamura Y, Ohno A, Fujimori N, Tamura T, Miyagahara T, Nakajima M, Kitano M.
Effectiveness and Safety of Enteroscopy-Assisted ERP-Guided Versus EUS-Guided Pancreatic Duct Drainage for Pancreaticojejunostomy Strictures: A Multicenter Observational Study
Dig Endosc. 2026 Mar;38(3):e70128.
Okamoto K, Hijioka S, Kobayashi N, Imaoka H, Hara K, Takeuchi S, Fujimori N, Sudo K, Horiguchi S, Takada R, Ono T, Terashima T, Shioji K, Kondo S, Furukawa T, Ueno M, Tsumura H, Tobimatsu K, Doi T, Asama H, Kawaguchi S, Kitano Y, Maeda O, Kobayashi S, Arima S, Unno M, Ohno E, Kawata K, Ashida R, Naganuma A, Murohisa G, Yamada R, Satake H, Kodama Y, Yokota I, Okuyama H, Shimizu S, Morizane C, Ueno M, Nagano H, Furuse J; Japan Oncology Network in Hepatobiliary and Pancreas.
Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N)
J Gastroenterol. 2026 Aug;61(8):1159-1169.*
Sano Y, Kajikawa R, Mizusawa J, Ioka T, Ozaka M, Nakamura S, Ito Y, Furuse J, Kobayashi S, Fukuda H, Okusaka T, Ikeda M, Miwa H, Sasahira N, Nagashima F, Ohkawa K, Yamazaki K, Kanai M, Yamashita T, Hara K, Takayama Y, Komatsu Y, Fujimori N, Hama N, Kamata K, Hisano T, Shimizu S, Tobimatsu K, Maeda S, Ueno M.
Comparison of chemoradiotherapy and gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer: an integrated analysis of two randomized phase II trials (JCOG2408A)
BMC Cancer. 2026 Feb 10;26(1):363.
Murakami M, Fujimori N, Matsumoto K, Ueda K, Nakata K, Nakamura M, Yamamoto T, Oda Y, Ito T, Ogawa Y.
Clinical Implications of Ki-67 Index, Grade and Hormonal Changes in Pancreatic Neuroendocrine Tumors: Insights Into Tumor Heterogeneity Based on Primary and Secondary Lesions
J Hepatobiliary Pancreat Sci. 2026 Feb;33(2):141-150.
Ogura T, Kuroda T, Matsuura T, Kitadai J, Kitagawa K, Itonaga M, Takeshita K, Matsumori T, Emori T, Takenaka M, Imai H, Mandai K, Shintani S, Fujimori N, Shiomi H, Asada M, Sagami R, Maruyama H, Ikeura T, Shimatani M, Nishikiori H, Matsumoto K, Kokubu M, Kamada H, Ishida Y, Hakoda A, Kitano M.
EUS-Guided Versus Percutaneous Transhepatic Drainage of Liver Abscesses: A Multicenter Endohepatology Study in Western Japan (EPIC-LA Study)
Dig Endosc. 2026 Jan;38(1):e70067.
Takahashi K, Ozawa E, Hiroshima Y, Sagami R, Hinokuchi M, Murakami M, Fujimori N, Koga T, Ishida Y, Ayuse T, Miyaaki H.
Effectiveness of maintaining oxygenation of a new high flow nasal cannula for endoscopic retrograde cholangiopancreatography during intravenous anesthesia
Trials. 2026 Jan 13;27(1):119.
Masuda A, Notohara K, Kodama Y, Inoue D, Umemura T, Ikeura T, Kanno A, Iwasaki E, Fujimori N, Seno H, Kikuta K, Nakase H, Uehara T, Abe S, Tsujimae M, Nakamura S, Kawano M, Masamune A.
Clinical manifestations of immunoglobulin G4-related gastrointestinal disease: a nationwide multicenter retrospective study
J Gastroenterol. 2026 Jan;61(1):16-26.
Itonaga M, Ogura T, Takenaka M, Matsumoto K, Shiomi H, Shintani S, Kamada H, Yamashita T, Mandai K, Asada M, Imai H, Takeshita K, Ikeura T, Fujimori N, Kinoshita M, Ikezawa K, Sugimori S, Kitagawa K, Sagami R, Kokubu M, Kuroda T, Nishioka N, Hatamaru K, Minaga K, Wan K, Shimokawa T, Kitano M.
Adverse events of EUS-guided biliary drainage for malignant biliary obstruction: a large multicenter study
J Hepatobiliary Pancreat Sci. 2026 Mar;33(3):228-239.
Komori Y, Hijioka S, Nagashio Y, Harai S, Yamashige D, Onuma K, Fujisaki K, Agarie D, Okamoto K, Yagi S, Fukuda S, Kuwada M, Joshua Josef Torres, Ueda K, Fujimori N, Saito Y, Ogawa Y, Okusaka T.
Efficacy of the Stent-in-Stent Technique as a Rescue Method for Removing Embedded Metallic Biliary Stents
DEN Open. 2025 Dec 17;6(1):e70246.
Matsumoto R, Kikuta K, Takikawa T, Nakai Y, Takenaka M, Oki K, Ohno E, Ito K, Fujimori N, Katanuma A, Masuda A, Hori Y, Ikeura T, Suzuki R, Yamamoto S, Sogame Y, Kawashima H, Ito T, Okuwaki K, Itoi T, Takayama Y, Nakamura A, Terai S, Matsumoto K, Kuwatani M, Kishiwada M, Shigekawa M, Matsumori T, Inatomi O, Hatta W, Irisawa A, Unno M, Takeyama Y, Masamune A, Japan Pancreatitis Study Group for Chronic Pancreatitis
Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer
J Gastroenterol. 2026 Jan; 61(1): 105-116.
Ohno A, Fujimori N, Matsumoto K, Haji S, Sugahara O, Takeno A, Yamamoto T, Suenaga A, Kakehashi S, Ueda T, Murakami M, Teramatsu K, Ueda K, Oono T, Oda Y, Nakayama KI, Ogawa Y.
Role of the transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma
Oncogene. 2026 Jan; 45(2): 307-321.
Itonaga M, Takenaka M, Ikezawa K, Ikeura T, Shimatani M, Asada M, Fujimori N, Sagami R, Ogura T, Imai H, Matsumoto K, Shintani S, Shiomi H, Hatamaru K, Minaga K, Takada R, Wan K, Shimokawa T, Kitano M.
Balloon Enteroscopy-Assisted ERCP Versus Endoscopic Ultrasound-Guided Biliary Drainage for Unresectable Malignant Biliary Obstruction in Patients With Surgically Altered Anatomy: A Multicenter Prospective Registration Study
Dig Endosc. 2025 Nov;37(11):1179-1189.
Ohba A, Ozaka M, Mizusawa J, Okusaka T, Kobayashi S, Yamashita T, Ikeda M, Yasuda I, Sugimori K, Sasahira N, Ikezawa K, Miki I, Okano N, Mizuno N, Furukawa M, Shirakawa H, Sano Y, Katayama H, Furuse J, Ueno M; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial
J Clin Oncol. 2025 Nov;43(31):3345-3354.
Murakami M, Fujimori N, Suenaga A, Ueda T, Kakehashi S, Furuta A, Ohno A, Matsumoto K, Takamatsu Y, Ueda K, Ogawa Y.
Efficacy and Safety of Duodenal Stenting for Malignant Gastric Outlet Obstruction: Insights From a 15-year Single-Center Experience
DEN Open. 2025 Aug 25;6(1):e70192.
Ogura T, Tanisaka Y, Sekine M, Kobayashi K, Maruyama H, Hirai S, Shiomi H, Shigekawa M, Kuwatani M, Ikezawa K, Itonaga M, Takenaka M, Hijioka S, Ikeura T, Doi S, Fujimori N, Koizumi K, Nakai Y, Inoue T, Mukai S, Matsumoto K, Minami R, Mandai K, Matsuda A, Iwashita T, Kawashima H, Itoi T.
Japanese Multi-Institution Study of Success Rates of Wire-Guided Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography in Relation to Guidewire tip Length (With Video)
DEN Open. 2025 Jun 16;6(1):e70144.
Minoda Y, Suzuki Y, Ogino H, Nagatomo S, Xiaopeng Bai, Esaki M, Wada M, Tanaka Y, Hata Y, Fujimori N, Umekita S, Tsurumaru D, Ota M, Oki E, Ihara E, Ogawa Y.
Traction-assisted endoscopic ultrasound-guided fine-needle biopsy using the clip-with-thread method for small gastric subepithelial lesions: Randomized controlled trial (with video)
Dig Endosc. 2025 May;37(5):512-520.
Hirano H, Hirata K, Honma Y, Morizane C, Machida N, Kato K, Okusaka T, Boku N, Sekine S, Hiraoka N, Mizusawa J, Sano Y, Shibuya Y, Takahashi M, Fujimori N, Nomura M, Doki Y, Ueno M, Yoshikawa T, Takeuchi H.
Prognostic factors for overall survival in advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: a post hoc analysis of JCOG1213.
ESMO Gastrointest Oncol. 2025 May 16:8:100178.
Koga T, Ishida Y, Hashigo S, Shimokawa Y, Harima H, Okamoto K, Ohno A, Miyagahara T, Fujita T, Fukuchi S, Takahashi K, Taguchi H, Araki N, Ohtsuka Y, Uekitani T, Tsuneyoshi K, Akiyama T, Ishigaki N, Maruo T, Saito H, Ihara R, Yamasuji A, Oe S, Yoshinari M, Sagami R, Fujimori N, Fukuda Y, Ozawa E, Jikuya K, Shinohara H, Sen-Yo M, Ueki T, Tsuchiya N, Kitaguchi T, Matsumoto K, Fukuyama M, Hirai F.
Feasibility and safety of EUS-guided biliary drainage in inexperienced centers: a multicenter study in southwest Japan
Gastrointest Endosc. 2025 Apr;101(4):843-852.e2.
Takeshita K, Hijioka S, Ikezawa K, Ogura T, Kuwatani M, Fujimori N, Doi S, Endo M, Matsubara S, Yamada R, Mashima H, Kataoka M, Takada R, Okuda A, Ohno A, Katsukura N, Suzuki H, Tanaka T, Sekine M, Kitamura H, Okusaka.
Uncovered Self Expandable Metallic Stent with an Ultra Thin Delivery Sheath in Unresectable Malignant Hilar Biliary Obstruction: A Multicenter Prospective Observational Study
Dig Dis Sci. 2025 Apr;70(4):1560-1572.
Oyama K, Nakata K, Abe T, Hirotaka K, Fujimori N, Kiyotani K, Iwamoto C, Ikenaga N, Morisaki S, Umebayashi M, Tanaka H, Koya N, Nakagawa S, Tsujimura K, Yoshimura S, Onishi H, Nakamura Y, Nakamura M and Morisaki T.
Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study
Frontiers in Immunology. 2025 Apr 3:16:1571182
Shibuki T, Ikeda M, Yokoyama M, Sano Y, Furuse J, Kobayashi S, Ohba A, Todaka A, Horie T, Shoji K, Kanai M, Nishina T, Kumamoto Y, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Miwa H, Ozaka M, Ueno M.
Depth of response in patients with locally advanced pancreatic cancer treated with first-line chemotherapy: a supplementary analysis of JCOG1407
Pancreatology. 2025 Mar;25(2):275-283.
Ikeura T, Takaori A, Kikuta K, Ito K, Takikawa T, Eguchi T, Inoue T, Hori Y, Nakamura K,
Takenaka M, Sogame Y, Takagi T, Fujimori N, Yamamoto S, Nakamura A, Sakai T, Sakai A, Tamura T, Saito T, Fujita K, Kanno A, Hosono K, Iwata K, Irisawa A, Okamoto K, Kuwatani M, Naganuma M, Masamune A and Takeyama Y, Japan Pancreatitis Study Group for CP
Complete clearance of painless pancreatic stones with endotherapy prevents the progression of pancreatic parenchyma atrophy in patients with chronic pancreatitis: Multicenter cohort study
Dig Endosc. 2025 Jun;37(6): 638-650.
Takeshita K, Hijioka S, Ikezawa K, Ogura T, Kuwatani M, Fujimori N, Doi S, Endo M, Matsubara S, Yamada R, Mashima H, Kataoka M, Takada R, Okuda A, Ohno A, Katsukura N, Suzuki H, Tanaka T, Sekine M, Kitamura H, Okusaka.
Uncovered Self‑Expandable Metallic Stent with an Ultra‑Thin Delivery Sheath in Unresectable Malignant Hilar Biliary Obstruction: A Multicenter Prospective Observational Study
Dig Dis Sci. 2025 Apr;70(4):1560-1572.
Fujimori N, Fujita N, Murakami M, Ohno A, Matsumoto K, Teramatsu K, Ueda K, Wada N, Takao S, Okamoto D, Ishigami K, Ito T, Ogawa Y.
Usefulness of semi-automated 3D volumetric assessment of liver tumor burden for patients with unresectable pancreatic neuroendocrine tumor: A pilot study
Pancreas. 2025 Feb 1;54(2):e122-e129.
Ikenaga N, Nakata K, Abe T, Watanabe Y, Ideno N, Murakami M, Ueda K, Fujimori N, Fujita N, Ishigami K, Ogawa Y, Nakamura M.
Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma
Surgery. 2025 Feb:178:108958.
Sano T, Kikuta K, Takikawa T, Matsumoto R, Okazaki K, Takeyama Y, Masamune A; Japan Pancreatitis Study Group for AIP (JPSG-AIP).
Serum IgG4-negative and IgG4-positive type 1 autoimmune pancreatitis present with different clinicopathological features: An analysis of a nationwide survey in Japan
Pancreatology. 2025 Feb;25(1):82-88.
Ohno A, Fujimori N, Kaku T, Matsumoto K, Murakami M, Teramatsu K, Ueda K, Hijioka M, Aso A, Ogawa Y.
Puncture angle on an endoscopic ultrasound image is independently associated with unsuccessful guidewire maniqulation of endscopic ultrasound-guided hepaticogastrostomy: a retrospective study in Japan.
Clin Endosc. 2024 Sep;57(5):656-665.
Ohno A, Fujimori N, Kaku T, Shimokawa Y, Miyagahara T, Suehiro Y, Gerodias A, Kakehashi S, Matsumoto K, Murakami M, Ueda K, Ogawa Y.
Feasibility of Endoscopic Ultrasound-Guided Hepaticogastrostomy for Malignant Hilar Biliary Obstruction
Dig Dis Sci. 2025 Jan;70(1):419-428.
Saito T, Takenaka M, Kuwatani M, Doi S, Ohyama H, Fujisawa T, Masuda A, Iwashita T, Shiomi H, Hayashi N, Iwata K, Maruta A, Mukai T, Matsubara S, Hamada T, Inoue T, Matsumoto K, Hirose S, Fujimori N, Kashiwabara K, Kamada H, Hashimoto S, Shiratori T, Yamada R, Kogure H, Nakahara K, Ogura T, Kitano M, Yasuda I, Isayama H, Nakai Y; WONDERFUL study group in Japan and collaborators.
WONDER-02: plastic stent vs. lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic pseudocysts-study protocol for a multicentre randomised non-inferiority trial.
Trials. 2024 Aug 24;25(1):559.
Ogura T, Ishiwatari H, Hijioka S, Takeshita K, Sato J, Takenaka M, Fukunaga T, Omoto S, Fujimori N, Ohno A, Hatamaru K, Tamura T, Imai H, Yamada M, Hakoda A, Nishikawa H, Kitano M.
Multicenter study comparing EUS-guided hepaticogastrostomy and ERCP for malignant biliary obstruction in patients with accessible papillae
J Hepatobiliary Pancreat Sci. 2024 Sep;31(9):680-687.
Ishiwatari H, Kawabara T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H, Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Endoscopic nasobiliary drainage versus endoscopic biliary stenting for preoperative biliary drainage in patients with malignant hilar biliary obstruction: A propensity score matched multicenter comparative study
Dig Endosc. 2024 Jun;36(6):726-734.
Koga T, Ishida Y, Hashigo S, Shimokawa Y, Harima H, Okamoto K, Ohno A, Miyagahara T, Fujita T, Fukuchi S, Takahashi K, Taguchi H, Araki N, Ohtsuka Y, Uekitani T, Tsuneyoshi K, Akiyama T, Ishigaki N, Maruo T, Saito H, Ihara R, Yamasuji A, Oe S, Yoshinari M, Sagami R, Fujimori N, Fukuda Y, Ozawa E, Jikuya K, Shinohara H, Sen-Yo M, Ueki T, Tsuchiya N, Kitaguchi T, Matsumoto K, Fukuyama M, Hirai F.
Feasibility and safety of endoscopic ultrasound-guided biliary drainage in inexperienced centers: a multicenter study in Southwest Japan.
Gastrointest Endosc. 2024 Sep 13:S0016-5107(24)03495-3.
Matsumoto K, Fujimori N, Ichihara K, Takeno A, Murakami M, Ohno A, Kakehashi S, Teramatsu K, Ueda K, Nakata K, Sugahara O, Yamamoto T, Matsumoto A, Nakayama KI, Oda Y, Nakamura M, Ogawa Y.
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction.
J Gastroenterol. 2024 Jul;59(7):629-640.
Murakami M, Fujimori N, Takamatsu Y, Ito T, Matsumoto K, Kakehashi S, Ohno A, Teramatsu K, Ueda K, Ishigami K and Ogawa Y.
Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice
Jpn J Clin Oncol. 2024 Jun 1;54(6):647-657.
Takikawa T, Kikuta K, Sano T, Ikeura T, Fujimori N, Umemura T, Naitoh I, Nakase H, Isayama H, Kanno A, Kamata K, Kodama Y, Inoue D, Ido A, Ueki T, Seno H, Yasuda H, Iwasaki E, Nishino T, Kubota K, Arizumi T, Tanaka A, Uchida K, Matsumoto R, Hamada S, Nakamura S, Okazaki K, Takeyama Y, Masamune A; Japan Pancreatitis Study Group for AIP.
Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan
Pancreatology. 2024 May;24(3):335-342.
Shibata K, Fujimori N, Oono T, Motooka D, Okuzaki D, Sonoda K, Ogawa Y, Yamasaki S.
Single-cell analysis for identification of T-cell clonotypes associated with IgG4 production of autoimmune pancreatitis.
Gastroenterol Rep (Oxf). 2023 Dec 8:11:goad071.
Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y.
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
J Gastroenterol. 2023 Jun;58(6):586-597.
Miyagahara T, Fujimori N, Ueda K, Takamatsu Y, Matsumoto K, Teramastu K, Takaoka T, Suehiro Y, Shimokawa Y, Omori K, Niina Y, Tachibana Y, Akashi T, Oono T, Ogawa Y.
Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Asia Pac J Clin Oncol. 2023 Aug;19(4):533-541.
Mizuno N, Ioka T, Ogawa G, Nakamura S, Hiraoka N, Ito Y, Katayama S, Takada R, Kobayashi S, Ikeda M, Muwa H, Okano N, Kuramochi H, Sekimoto M, Okusaka T, Ozaka M, Todaka A, Gotoh K, Tobimatsu K, Yamaguchi H, Nakagohri T, Kajiura S, Sudo K, Okamura K, Shimizu S, Shirakawa H, Kato N, Sano K, Iwai T, Fujimori N, Ueno M, Ishii H, Furuse J and Hepatobiliary and Pancreatic Oncology Group (HBPOG) of Japan Clinical Oncology Group (JCOG)
Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106
Jpn J Clin Oncol. 2023 Jul 31;53(8):704-713.
Fujita N, Ushijima Y, Itoyama M, Okamoto D, Ishimatsu K, Wada N, Takao S, Murayama R, Fujimori N, Nakata K, Nakamura M, Yamamoto T, Oda Y, Ishigami K.
Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy of preoperative neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma.
Eur J Radiol. 2023 May; 162:110756.
Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG).
A randomized phase Ⅱ study of modified FOLFIRINOX versus gemcitabine plusnab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Eur J Cancer. 2023 Mar;181:135-144.
Ikenaga N, Nakata K, Abe T, Ideno N, Fujimori N, Oono T, Fujita N, Ishigami K, Nakamura M.
Risks and benefits of pancreaticoduodenectomy in patients aged 80 years and over
Langenbecks Arch Surg. 2023 Feb 27;408(1):108.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J, Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
Lancet. 2023 Jan 21;401(10372):195-203.
Ikenaga N, Nakata K, Hayashi M, Nakamura S, Abe T, Ideno N, Murakami M, Fujimori N, Fujita N, Isoda T, Baba S, Ishigami K, Oda Y, Nakamura M.
Clinical Implications of FDG PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy
J Gastrointest Surg. 2023 Feb;27(2):337-346.
Ohno A, Fujimori N, Kaku T, Takamatsu Y, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Hijioka M, Kawabe K, Harada N, Nakamuta M, Aso A, Oono T, Ogawa Y.
Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
Dig Dis Sci. 2022 Dec;67(12):5676-5684.
Minaga K, Kitano M, Uenoyama Y, Hatamaru K, Shiomi H, Ikezawa K, Miyagahara T, Imai H, Fujimori N, Matsumoto H, Shimokawa Y, Masuda A, Takenaka M, Kudo M, Chiba Y.
Feasibility and efficacy of endoscopic reintervention after covered metal stent placement for EUS-guided hepaticogastrostomy: A multicenter experience.
Endosc Ultrasound. 2022 Nov-Dec;11(6):478-486.
Shibata K. Motozono C, Nagae M, Shimizu T, Ishikawa E, Motooka D, Okuzaki D, Izumi Y, Takahashi M, Fujimori N, Wing JB, Hayano T, Asai Y, Bamba T, Ogawa Y, Furutani-Seiki Makoto, Shirai M, Yamasaki S.
Symbiotic bacteria-dependent expansion of MR1-reactive T cells causes autoimmunity in the absence of Bcl11b
Nat Commun. 2022 Nov 14;13(1):6948.
Teramatsu K, Oono T, Oyama K, Fujimori N, Murakami M, Yasumori S, Ohno A, Matsumoto K, Takeno A, Nakata K, Nakamura M, Ogawa Y.
Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
BMC Cancer. 2022 Nov 4;22(1):1134.
Ohno A, Fujimori N, Kaku T, Hijioka M, Kawabe K, Harada N, Nakamuta M, Oono T, Ogawa Y.
The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center.
Clin Endosc. 2022 Nov;55(6):784-792.
Minoda Y, Esaki M, Ihara E, Nagatomo S, Nishioka K, Fujimori N, Ogino H, Bai X, Tanaka Y, Chinen T, Hu Q, Ota M, Umekita S, Yamamoto H, Ogawa Y.
Auxiliary diagnosis of subepithelial lesions by impedance measurement during endoscopic ultrasound guided fine-needle biopsy.
Gastrointest Endosc. 2023 May;97(5):977-984.
Shimizu K, Ito T, Irisawa A, Ohtsuka T, Ohara H, Kanno A, Kida M, Sakagami J, Sata N, Takeyama Y, Tahara J, Hirota M, Fujimori N, Masamune A, Mochida S, Enomoto N, Shimosegawa T, Koike K.
Evidence-based clinical practice guidelines for chronic pancreatitis 2021.
J Gastroenterol. 2022 Oct;57(10):709-724.
Kubota K, Oguchi T, Fujimori N, Yamada K, Naitoh I, Okabe Y, Iwasaki E, Masamune A, Ikeura T, Kamisawa T, Inoue D, Kumagi T, Ogura T, Kodama Y, Katanuma A, Hirano K, Inui K, Isayama H, Sakagami J, Nishino T, Kanno A, Kurita Y, Okazaki K, Nakamura S.
Steroid therapy has an acceptable role as the initial treatment in autoimmune pancreatitis patients with pancreatic cyst formation: based on a Japanese nationwide study. Collaborators.
J Hepatobiliary Pancreat Sci. 2023 May;30(5):664-677.
Ishiwatari H, Kawabata T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H, Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction.
Dig Dis Sci. 2023 Apr;68(4):1139-1147.
Minoda Y, Ihara E, Fujimori N, Nagatomo S, Esaki M, Hata Y, Bai X, Tanaka Y, Ogino H, Chinen T, Hu Q, Oki E, Yamamoto H, Ogawa Y.
Efficacy of ultrasound endoscopy with artificial intelligence for the differential diagnosis of non-gastric gastrointestinal stromal tumors.
Sci Rep 2022 Oct 5;12(1):16640.
Miki M, Fujimori N, Ueda K, Lee L, Murakami M, Takamatsu Y, Shimokawa Y, Niina Y, Oono T, Hisano T, Furukawa M, Ogawa Y.
Treatment effect and safety of nanoliposomal irinotecan with fluorouracil and folinic acid after gemcitabine-based therapy in patients with advanced pancreatic cancer: A multicenter, prospective observational study.
J Clin Med. 2022 Aug 30;11(17):5084.
Morizane C, Machida N, Honma Y, Okusaka T, Boku N, Kato K, Nomura S, Hiraoka N, Sekine S, Taniguchi H, Okano N, Yamaguchi K, Sato T, Ikeda M, Mizuno N, Ozaka M, Kataoka T, Ueno M, Kitagawa Y, Terashima M, Furuse J; Japan Clinical Oncology Group (JCOG).
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial
JAMA Oncol. 2022 Oct 1;8(10):1447-1455.
Minoda Y, Ihara E, Itaba S, Sumida Y, Haraguchi K, Aso A, Mizutani T, Osoegawa T, Esaki M, Nagatomo S, Nishioka K, Muta K, Bai X, Ogino H, Fujimori N, Tsurumaru D, Ohuchida K, Qingjiang H, Oki E, Yamamoto H, Ogawa Y.
Negligible procedure-related dissemination risk of mucosal incision-assisted biopsy for gastrointestinal stromal tumors versus endoscopic ultrasound-guided fine-needle aspiration/biopsy.
Surg Endosc. 2023 Jan;37(1):101-108.
Takamatsu Y, Fujimori N, Miyagahara T, Suehiro Y, Kaku T, Kawabe K, Ohno A, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Oono T, Ogawa Y.
The Glasgow Prognostic Score and stricture site can predict prognosis after endoscopic duodenal stent placement for malignant gastric outlet obstruction.
Sci Rep. 2022 Jun 13;12(1):9746.
Murakami M, Fujimori N, Matsumoto K, Ohno A, Teramatsu K, Takamatsu Y, Takeno A, Ueda K, Oono T, Ito T, Ogawa Y.
A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a singlecenter experience.
Endocr J. 2022 Oct 28;69(10):1201-1209.
Matsumoto K, Fujimori N, Hata Y, Minoda Y, Murakami M, Teramatsu K, Takamatsu Y, Takeno A, Oono T, Ihara E, Nakata K, Nakamura M, Yamamoto T, Koga Y, Oda Y, Ito T, Ogawa Y.
Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
Dig Dis. 2023;41(2):316-324.
Kitano M, Yoshida M, Ashida R, Kita E, Katanuma A, Itoi T, Mikata R, Nishikawa K, Matsubayashi H, Takayama Y, Kato H, Takenaka M, Ueki T, Kawashima Y, Nakai Y, Hashimoto S, Shigekawa M, Nebiki H, Tsumura H, Okabe Y, Ryozawa S, Harada Y, Mitoro A, Sasaki T, Yasuda H, Miura N, Ikemoto T, Ozawa E, Shioji K, Yamaguchi A, Okuzono T, Moriyama I, Hisai H, Fujita K, Goto T, Shirahata N, Iwata Y, Okabe Y, Hara K, Hashimoto Y, Kuwatani M, Isayama H, Fujimori N, Masamune A, Hatamaru K, Shimokawa T, Okazaki K, Takeyama Y, Yamaue H; Committee of Clinical Research, Japan Pancreas Society.
Needle tract seeding after endoscopic ultrasound-guided tissue acquisition of pancreatic tumors: A nationwide survey in Japan.
Dig Endosc. 2022 Nov;34(7):1442-1455.
Ogura T, Ishiwatari H, Fujimori N, Iwasaki E, Ishikawa K, Satoh T, Kaneko J, Sato J, Oono T, Matsumoto K, Fukuhara S, Kayashima A, Hakoda A, Higuchi K.
Propensity score matching analysis for adverse events of EUS-guided biliary drainage in advanced elderly patients (PEACE study).
Therap Adv Gastroenterol. 2022 May 17;15:17562848221092612.
Murakami M, Fujimori N, Ohno A, Matsumoto K, Teramatsu K, Takamatsu Y, Takeno A, OonoT, Abe T, Ideno N, Ikenaga N, Nakata K, Nakamura M, Ishigami K, Ogawa Y.
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: A single-center retrospective study
Discov Oncol. 2022 Jan 3;13(1):2.
Fujimori N, Minoda Y, Ogawa Y.
What is the best modality for diagnosing pancreatic cancer?
Dig Endosc. 2022 34:744-746.
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
J Gastroenterol. 2021 Nov;56(11):1033-1044.
Ito T, Fujimori N, Honma Y, Kudo A, Hijioka S, Katsushima S, Kimura Y, Fukutomi A, Hisamatsu S, Nakajima A, Shimatsu A.
Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study.
Asia Pac J Clin Oncol. 2021 Oct;17(5):e153-e161.
Okuno H, Ogino H, Ihara E, Nishioka K, Tanaka Y, Chinen T, Kohjima M, Oono T, Tanaka M, Goya T, Fujimori N, Iboshi Y, Gotoda T, Ogawa Y.
Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified
BMC Gastroenterol. 2021 Feb 16;21(1):73.
Fujimori N, Osoegawa T, Aso A, Itaba S, Minoda Y, Murakami M, Matsumoto K, Teramatsu K, Takamatsu Y, Takaoka T, Oono T, Ihara E, Yoshizumi T, Ohtsuka T, Nakamura M, Ogawa Y.
Efficacy of early endoscopic ultrasound-guided transluminal drainage for postoperative pancreatic fistula
Can J Gastroenterol Hepatol. 2021 Jan 25:6691705.
Masamune A, Kikuta K, Kume K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K, Japan Pancreas Society
Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019.
J Gastroenterol. 2020 Nov;55(11):1062-1071.
Minaga K, Takenaka M, Ogura T, Tamura T, Kuroda T, Kaku T, Uenoyama Y, Noguchi C, Nishikiori H, Imai H, Sagami R, Fujimori N, Higuchi K, Kudo M, Chiba Y, Kitano M.
Endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction with surgically altered anatomy: a multicenter prospective registration study
Therap Adv Gastroenterol. 2020 Jul 29;13:1756284820930964.
Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Japan Pancreas Society.
Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016.
Pancreatology. 2020 Jun;20(4):629-636.
Fujimori N, Miki M, Lee L, Matsumoto K, Takamatsu Y, Takaoka T, Teramatsu K, Suehiro Y, Murakami M, Igarashi H, Oono T, Ohtsuka T, Nakamura M, Koga Y, Oda Y, Ito T, Ogawa Y.
Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years.
Pancreatology. 2020 Jun;20(4):709-715.
Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Collaborators.
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.
J Gastroenterol. 2020 Apr;55(4):462-470.
Fujita N, Nishie A, Asayama Y, Ishigami K, Fujimori N, Ito T, Honda H
Intravoxel incoherent motion magnetic resonance imaging for assessment of chronic pancreatitis with special focus on its early stage.
Acta Radiol. 2020 May;61(5):579-585.
Miki M, Oono T, Fujimori N, Takaoka T, Kawabe K, Miyasaka Y, Ohtsuka T, Saito D, Nakamura M, Ohkawa Y, Oda Y, Suyama M, Ito T, Ogawa Y.
CLEC3A, MMP7, and LCN2 as Novel Markers for Predicting Recurrence in Resected G1 and G2 Pancreatic Neuroendocrine Tumors.
Cancer Med. 2019 Jul;8(8):3748-3760.
Miyasaka Y, Ohtsuka T, Kimura R, Matsuda R, Mori Y, Nakata K, Kakihara D, Fujimori N, Ohno T, Oda Y, Nakamura M.
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery.
Ann Surg Oncol. 2019 May;26(5):1528-1534.
Miki M, Fujimori N, Oono T, Kawabe K, Ohno A, Matsumoto K, Teramatsu K, Tachibana Y, Ogawa Y.
Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.
J Dig Dis. 2019 Mar;20(3):152-158.
Toriyama K, Hijioka S, Komoto I, Kobayashi N, Okusaka T, Ku Y, Sudo K, Furukawa M, Tachibana Y, Takahashi M, Yasuda H, Nakamori S, Honma Y, Kida M, Fujimori N, Kashiwada T, Masui T, Ishii H, Tsuchiya Y, Isaji S, Mizuno N, Hara K, Sakamine M, Imamura M, Kagimura T, Ito T.
Study Protocol for Prospective Observational Study 1 on the Prognosis of Patients with Unresectable Advanced Gastrointestinal and Pancreatic Neuroendocrine Tumors (PROP-UP 1 Study) in Japan.
J Clin Trials Vol 8(4) 2018.
Ohtsuka T, Gotoh Y, Nakashima Y, Okayama Y, Nakamura S, Morita M, Aly MYF, Velasquez VVDM, Mori Y, Sadakari Y, Nakata K, Miyasaka Y, Ishigami K, Fujimori N, Mochidome N, Oda Y, Shimizu S, Nakamura M.
Role of SpyGlass-DStm in the preoperative assessment of pancreatic intraductal papillary mucinous neoplasm involving the main pancreatic duct.
Pancreatology 2018 Jul;18(5):566-571.
Yasunaga K, Ito T, Miki M, Ueda K, Fujiyama T, Tachibana Y, Fujimori N, Kawabe K, Ogawa Y.
Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells.
Biomed Res Int 2018 May 17:2018:8719397.
L Lee , Ito T, Igarashi H, Miki M, Fujimori N, Kawabe K, Jensen RT, Ogawa Y.
Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors.
Cancer Chemother Pharmacol. 81:163-169, 2018.
Ueda K, Kawabe K, Lee L, Tachibana Y, Fujimori N, Igarashi H, Oda Y, Jensen RT, Takayanagi R, Ito T.
Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.
Pancreas. 46:476-481, 2017.
Niina Y, Ito T, Ueda K, Lee L, Igarashi H, Hijioka M, Takaoka T, Fujiyama T, Miki M, Tachibana Y, Fujimori N, Ohtsuka T, Nakamura K, Kawabe K, Ogawa Y.
Effectiveness of endoscopic duodenal stenting for the management of patients with unresectable pancreatic cancer.
Gastroenterol Hepatol Endosc, 2: 1-5, 2017.
Fujimori N, Osoegawa T, Lee L, Tachibana Y, Aso A, Kubo H, Kawabe K, Igarashi H, Nakamura K, Oda Y, Ito T.
Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
Scand J Gastroenterol 51: 245-252, 2016.
Lee L, Igarashi H, Fujimori N, Hijioka M, Kawabe K, Oda Y, Jensen RT, Ito T.
Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine tumors:a single-center retrospective study.
Jpn J Clin Oncol 45: 1131-1138, 2015.
Kohjima M, Yoshimoto T, Enjoji M, Fukushima N, Fukuizumi K, Nakamura T, Kurokawa M, Fujimori N, Sasaki Y, Shimonaka Y, Murata Y, Koyama S, Kawabe K, Haraguchi K, Sumida Y, Harada N, Kato M, Kotoh K, Nakamuta M.
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
World J Gastroenterol. 21:3291-9, 2015.
Hijioka M, Ito T, Igarashi H, Fujimori N, Lee L, Nakamura T, Jensen RT, Takayanagi R.
Serum Chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumor.
Cancer Sci 105: 1464-1471, 2014.
Niina Y, Ito T, Oono T, Nakamura T, Fujimori N, Igarashi H, Sakai Y, Takayanagi R.
A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
Pancreatology. 14:201-10. 2014.
Fujimori N, Igarashi H, Asou A, Kawabe K, Lee L, Oono T, Nakamura T, Niina Y, Hijioka M, Uchida M, Kotoh K, Nakamura K, Ito T, Takayanagi R.
Endoscopic approach through the minor papilla in the management of pancreatic diseases.
World J Gastrointest Endosc 5: 81-88, 2013.
Uchida M, Ito T, Nakamura T, Igarashi H, Oono T, Fujimori N, Kawabe K, Suzuki K, Jensen RT, Takayanagi R.
ERK pathway and sheddases play an essential role in ethanol-induced CX3CL1 release in pancreatic stellate cells.
Lab Invest.93:41-53. 2013.
Nakamura T, Ito T, Igarashi H, Uchida M, Hijioka M, Oono T, Fujimori N, Niina Y, Suzuki K, Jensen RT, Takayanagi R.
Cytosolic double-stranded DNA as a damage-associated molecular pattern induces the inflammatory response in rat pancreatic stellate cells: a plausible mechanism for tissue injury-associated pancreatitis.
Int J Inflam.2:504128.2012.
Igarashi H, Ito T, Oono T, Nakamura T, Fujimori N, Niina Y, Hijioka M, Uchida M, Lee R, Iwao R, Nakamura K, Kotoh K, Takayanagi R.
Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases.
J Dig Dis.13:274-9, 2012.
Fujimori N, Oono T, Igarashi H, Ito T, Nakamura T, Uchida M, Coy DH, Jensen RT, Takayanagi R.
Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase.
Peptides. 32:2067-76, 2011.
Nakamura T, Ito T, Oono T, Igarashi H, Fujimori N, Uchida M, Niina Y, Yasuda M, Suzuki K, Takayanagi R.
Bacterial DNA promotes proliferation of rat pancreatic stellate cells thorough toll-like receptor 9: potential mechanisms for bacterially induced fibrosis.
Pancreas. 40:823-31, 2011.
Ito T, Nakamura T, Fujimori N, Niina Y, Igarashi H, Oono T, Uchida M, Kawabe K, Takayanagi R, Nishimori I, Otsuki M, Shimosegawa T.
Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.
J Dig Dis. 12:210-6, 2011.
Ito T, Otsuki M, Igarashi H, Kihara Y, Kawabe K, Nakamura T, Fujimori N, Oono T, Takayanagi R, Shimosegawa T.
Epidemiological Study of Pancreatic Diabetes in Japan in 2005: A Nationwide Study.
Pancreas. 39:829-835, 2010.
Gibo J, Ito T, Kawabe K, Hisano T, Inoue M, Fujimori N, Oono T, Arita Y and Nawata H.
Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.
Lab Invest. 85:75-89, 2005.
著書・総説
安森 翔、藤森 尚、植田 圭二郎、上田 孝洋、伊藤 鉄英、小川 佳宏
【自己免疫性膵炎とIgG4関連疾患における最新の知見】
自己免疫性膵炎におけるステロイド治療後の再燃の有無と縮小率の経時的変化
胆と膵 47(8); 795-799, 2026.8
藤森 尚、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【慢性膵炎診療の現状と課題】
膵外分泌機能不全診療の現状と課題
膵臓 41(1); 34-39, 2026.3
伊藤 鉄英、安森 翔、高松 悠、植田 圭二郎、平松 真祐、池田 純香、三嶋 一登、藤森 尚
【胆膵疾患国際診療ガイドラインのすべて～国内外ガイドラインの比較検証～】
慢性膵炎診療ガイドライン2021改訂第3版の概要と国際ガイドラインとの比較
胆と膵 47(3); 303-309, 2026.3
伊藤 鉄英、安森 翔、高松 悠、植田 圭二郎、村上 正俊、松本 一秀、五十嵐 久人、三嶋 一登、藤森 尚
【膵・消化管神経内分泌腫瘍(NEN)診療ガイドライン第3版とNEN Policy Recommendation】
トピックス 膵神経内分泌腫瘍に対する低酸素誘導因子HIF-2α阻害剤の治療薬としての可能性
胆と膵 47(2); 227-230, 2026.2
植田 圭二郎、帆北 理紗子、伊豆 将貴、古田 朗人、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、藤森 尚、伊藤 鉄英、小川 佳宏
【膵・消化管神経内分泌腫瘍(NEN)診療ガイドライン第3版とNEN Policy Recommendation】
膵機能性神経内分泌腫瘍の存在および局在診断 ガイドライン第3版改訂を受けて インスリノーマ
胆と膵 47(2); 153-157, 2026.2
村上 正俊、藤森 尚、帆北 理紗子、伊豆 将貴、末永 顕彦、上田 孝洋、梯 祥太郎、古田 朗人、大野 彰久、松本 一秀、植田 圭二郎、小川 佳宏
【ERCPトラブルシューティングを極める】
ERCPにおけるトラブルシューティング 各論:ERCP手技関連
十二指腸ステント留置に関するトラブル時の対応をどうする?【動画付】
胆と膵 46(臨増特大); 1249-1256, 2025.10
藤森 尚、末永 顕彦、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【膵疾患の診療】
(第1部)炎症性疾患 慢性膵炎 膵外分泌機能不全
臨床消化器内科 40(8); 895-901, 2025.7
松本 一秀、藤森 尚、赤木 健哉、川口 夢佳、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、安森 翔、村上 正俊、植田 圭二郎、伊藤 鉄英、小川 佳宏
【膵癌はナゼ治りにくいのか?】
膵癌治療の最前線 化学療法
臨牀と研究 102(4); 395-400, 2025.4
村上 正俊、藤森 尚、松本 一秀、植田 圭二郎、伊藤 鉄英、小川 佳宏
【膵・消化管神経内分泌腫瘍の診療アップデート】
膵神経内分泌腫瘍に対する薬物療法
臨床消化器内科 40(5); 576-583, 2025.4
植田 圭二郎、藤森 尚
【ここまでできる! プライマリケア-領域別で考えるプライマリケア医と専門医の役割】
(第7章)肝・胆・膵 腹痛,消化不良症,膵石灰化 慢性膵炎
内科 135(4); 892-897, 2025.4
藤森 尚、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、安森 翔、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【膵外分泌機能不全を再考する】
膵外分泌機能不全の原因と病態 慢性膵炎における膵外分泌機能不全
肝胆膵 90(2); 157-163, 2025.2
藤森 尚、末永 顕彦、川口 夢佳、赤木 健哉、上田 孝洋、梯 祥太郎、安森 翔、大野 彰久、松本 一秀、村上 正俊、植田 圭二郎、伊藤 鉄英、小川 佳宏
【膵外分泌機能不全を究める】
膵外分泌機能不全に伴う糖尿病の病態と治療
胆と膵 46(1); 55-60, 2025.1
高松 悠、伊藤 鉄英、三船 繭子、平賀 ちひろ、新名 雄介、岡本 亮子、植田 圭二郎、藤岡 真之、藤山 隆、藤森 尚
【膵外分泌機能不全を究める】
膵外分泌機能不全に対する栄養サポート
胆と膵 46(1); 61-64, 2025.01
村上 正俊、藤森 尚、宮ケ原 典、赤木 健哉、川口 夢佳、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、松本 一秀、植田 圭二郎、小川 佳宏
【希少領域、治療困難例における膵・胆道癌の薬物療法】
治療困難な膵・胆道癌の薬物療法 閉塞性・拘束性肺障害合併胆道癌・膵癌の薬物療法および薬剤性肺障害について
胆と膵 45(11); 1669-1675, 2024.11
藤森 尚、赤木 健哉、川口 夢佳、末永 顕彦、Gerodias Anthony R.、上田 孝洋、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【胆膵Interventional Endoscopyを極める】
トラブルシューティング 膵管ステント迷入
胆と膵 45(臨増特大); 1377-1383, 2024.10
藤森 尚、小森 康寛、末永 顕彦、植田 圭二郎、小川 佳宏
【スキルアップ内視鏡診療】胆膵 挿管・診断
経口胆道鏡をマスターする
消化器内視鏡 36(増刊号); 343-347, 2024.10
伊藤 鉄英、高松 悠、植田 圭二郎、村上 正俊、松本 一秀、藤森 尚
【膵胆道周囲の後腹膜腫瘍性病変の診断と治療】
膵胆道周囲の後腹膜腫瘍性病変 ～膵神経内分泌腫瘍～
胆と膵 45(9); 915-920, 2024.9
松本 一秀、藤森 尚、上田 孝洋、梯 祥太郎、大野 彰久、村上 正俊、植田 圭二郎、小川 佳宏
【今推しの肝胆膵研究手法と疾患モデル】
新規モデルによる肝胆膵研究 膵臓癌オルガノイドを用いたサブタイプ予測による予後解析
肝胆膵 89(2); 243-248, 2024.8
松本 一秀、藤森 尚、小川 佳宏
オルガノイド研究で膵がん治療を革新したい
国際医薬品情報 1255; 22-23, 2024.8
大野 彰久、藤森 尚、小森 康寛、末永 顕彦、梯 祥太郎、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、小川 佳宏
【日常診療での超音波検査のおさえどころ】
超音波検査の最新の進歩 胆膵のInterventional EUS
臨牀と研究 101(7); 58-59, 2024.7
藤森 尚（回答者）、松本 和幸（質問者；岡山大学病院消化器内科）
小径かつ低悪性度の膵神経内分泌腫瘍に対して経過観察した場合のデータは？経過観察は許容される？
週刊 日本医事新報 No.5215; 50-51, 2024.4
藤森 尚、村上 正俊、松本 一秀、大野 彰久、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
【超高齢社会（高齢化率21％以上）の膵疾患診療】
超高齢社会における膵神経内分泌腫瘍診断療
膵臓 39(1); 33-42, 2024.2
村上 正俊、藤森 尚、末永 顕彦、小森 康寛、梯 祥太郎、大野 彰久、松本 一秀、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
【神経内分泌腫瘍の新たな知見〜膵消化管神経内分泌腫瘍診療ガイドライン改定に向けて〜】
膵・消化管神経内分泌腫瘍におけるliquid biopsy診断
胆と膵 45(1); 25-31, 2024.1
藤森 尚、村上 正俊、蓑田 洋介、植田 圭二郎、伊藤 鉄英、小川 佳宏
【神経内分泌腫瘍の新たな知見〜膵消化管神経内分泌腫瘍診療ガイドライン改定に向けて〜】
AIを用いた膵神経内分泌腫瘍治療切除後再発予測モデルの構築と分析
胆と膵 45(1); 85-93, 2024.1
藤森 尚、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、伊藤 心二、吉住 朋晴、池永 直樹、仲田 興平、中村 雅史、小川 佳宏
【Stenting Bible～Renewal～ステントと挿入・留置手技にこだわる!!】炎症・液体貯留に対するStenting Strategy
術後膵液瘻に対するStenting Strategy
胆と膵 44(臨時増刊号); 1215-1221, 2023.10
大野 彰久、藤森 尚、寺松 克人、植田 圭二郎、小川 佳宏
【胆膵の画像・内視鏡診断の進歩-早期診断と正確な診断のために】
慢性膵炎の画像診断の進歩
臨牀消化器内科 38(13); 1632-1639, 2023.11
植田 圭二郎、伊藤 鉄英、河村 康平、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、藤森 尚、小川 佳宏
【胆道癌と膵癌のリスクファクター】
飲酒と発がん
胆と膵 44(9); 815-819, 2023.9
植田 圭二郎、藤森 尚
膵癌患者における糖尿病
胆と膵 44(9); 815-819, 2023.9
藤森 尚、大野 彰久、小森 康寛、松本 一秀、村上 正俊、寺松 克人、竹野 歩、植田 圭二郎、小川 佳宏
【胆膵疾患の内視鏡治療-beyond the ガイドライン!!】
慢性膵炎の合併症に対する内視鏡治療
消化器クリニカルアップデート 5(1); 53-60, 2023.6
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
【ソマトスタチン受容体を介した膵神経内分泌腫瘍の診断と治療の進歩】
ランレオチドによる膵NETに対する抗腫瘍治療
胆と膵 44(1); 53-59, 2023.1
藤森 尚、大野 彰久、植田 圭二郎、蓑田 洋介、小川 佳宏
【胆膵EUSのトラブルシューティング】
治療的EUS Peripancreatic/pancreatic fluid collection(PFD)ドレナージ ステントが迷入してしまった
消化器内視鏡 34(12); 1976-1980, 2022.12
伊藤 鉄英、高松 悠、植田 圭二郎、藤森 尚
【消化器領域の神経内分泌腫瘍の最新の知見】
膵・消化管神経内分泌腫瘍診療ガイドライン2019(第2版)
消化器内科 4(9); 29-34, 2022.10
藤森 尚、小川 佳宏
【エキスパートがお答えします!日常臨床のあるあるの疑問】
(第5章)肝・胆・膵
慢性膵炎の患者にはどのような生活指導が必要でしょうか？
内科 130(3); 502-505 2022.9
藤森 尚、松本 一秀、寺松 克人、竹野 歩、小川 佳宏
【胆道・膵疾患を診る-早期診断・早期治療のために】
胆膵疾患の総ざらい 慢性膵炎
内科 130(1); 77-83, 2022.7
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、竹野 歩、植田 圭二郎、伊藤 鉄英、小川 佳宏
【膵神経内分泌腫瘍-新たなる胎動2022-】基礎研究
膵神経内分泌腫瘍のリキッドバイオプシー
肝胆膵 84(6); 745-750, 2022.6
藤森 尚、大野 彰久、松本 一秀、村上 正俊、寺松 克人、竹野 歩、大野 隆真、小川 佳宏
【ブラッシュアップ!膵臓疾患の臨床検査】
膵臓の画像診断（CT・MRI・超音波内視鏡）
Medical Technology 50(5); 481-487, 2022.5
伊藤 鉄英、植田 圭二郎、高松 悠、松本 一秀、寺松 克人、竹野 歩、藤森 尚
【診療ガイドライン改訂後の膵炎診療】
慢性膵炎診療ガイドライン2021の改訂のポイント
肝胆膵 84(3); 321-328, 2022.3
村上 正俊、藤森 尚、上田 孝洋、大野 彰久、松本 一秀、寺松 克人、高松 悠、竹野 歩、大野 隆真、伊藤 鉄英、小川 佳宏
【膵神経内分泌腫瘍の病態解明と診療戦略】
膵神経内分泌腫瘍におけるLiquid biopsy診断と治療への応用
胆と膵 43(2); 141-145, 2022.2
藤森 尚、寺松 克人、高松 悠、上田 孝洋、平畠 啓介、大野 彰久、村上 正俊、安森 翔、松本 一秀、竹野 歩、大野 隆真、小川 佳宏
【Liquid biopsyは膵癌の診断・治療をどう変えるか?】
Liquid biopsyの膵癌切除後のサーベイランスへの応用
胆と膵 43(1); 71-75, 2022.1
伊藤 鉄英、植田 圭二郎、李 倫學、伊藤 寛治、藤森 尚
【膵・胆道癌における薬物療法のすべて】
がん薬物療法のエビデンス 膵神経内分泌腫瘍の薬物療法
胆と膵 42(臨増特大); 1167-1170, 2021.11
蓑田 洋介、長友 周三郎、西岡 慧、江崎 充、荻野 治栄、藤森 尚、大野 隆真、伊原 栄吉、大久保 文彦、佐々木 泰介、小田 義直、小川 佳宏
【膵と胆道の先天性形成異常～発生から臨床まで～】
異所性膵の診断
胆と膵 42(10); 943-946, 2021.10
新名 雄介、伊藤 鉄英、藤森 尚
【膵臓症候群(第3版)-その他の膵臓疾患を含めて-】
基本的な膵検査 膵内分泌能検査
日本臨床 別冊膵臓症候群; 15-16, 2021.6
藤森 尚、村上 正俊、松本 一秀、寺松 克人、高松 悠、竹野 歩、原 真児登、梯 祥太郎、 安森 翔、大野 隆真
膵・消化管神経内分泌腫瘍を巡る最近の話題
NEN診断と治療の新時代 膵・消化管神経内分泌腫瘍(GEP-NEN)の診断の進歩
Pharma Medica 39(5); 66-72, 2021.5
藤森 尚、原 真児登、梯 祥太郎、安森 翔、村上 正俊、松本 一秀、寺松 克人、高松 悠、竹野 歩、大野 隆真、伊藤 鉄英、小川 佳宏
【慢性膵炎診療の最前線】
慢性膵炎に対する薬物治療
胆と膵 42; 113-116, 2021.2
伊藤 鉄英、新名 雄介、李 倫學、藤森 尚、大野 隆真
【内分泌腺腫瘍(第2版)-基礎・臨床研究のアップデート-】
消化管神経内分泌腫瘍 消化管神経内分泌腫瘍の疫学
日本臨床 78(増刊4 内分泌腺腫瘍); 770-773, 2020.9
高松 悠、大野 隆真、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高岡 雄大、藤森 尚、上田 詩織、本坂亜希子、吉澤 裕子、南 晴奈、上野 寿弥、國栖 真理、横山 富美子、盛永 彩香、花田 浩和、濵﨑 正子
慢性膵炎患者に対する多職種連携のサポーティブ・ケアの試み
膵臓 35; 180-186, 2020
藤森 尚、高松 悠、松本 一秀、寺松 克人、大野 隆真、小川 佳宏
【慢性膵炎-ガイドライン改訂に向けて】
慢性膵炎の病態（1）成因、疫学
臨床消化器内科 35(11); 1297-1302, 2020.9
藤森 尚、村上 正俊、末廣 侑大、松本 一秀、寺松 克人、高松 悠、高岡 雄大、竹野 歩、大野 隆真、小川 佳宏
【膵炎・膵がん診療のUp To Date】
膵癌の日常診療－診断の進め方
臨床と研究 97(5); 537-542, 2020.5
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、伊藤 鉄英、小川 佳宏
【慢性膵炎診療2020】基礎研究・病態
喫煙と慢性膵炎の関係－基礎研究と疫学調査のデータから－
肝胆膵 80(2); 259-263, 2020.2
藤森 尚、松本 一秀、村上 正俊、加来 豊馬、末廣 侑大、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、森 泰寿、大塚 隆生、小川 佳宏
【胆膵疾患における緊急内視鏡～リスクマネジメントも含めて～】
EST後出血（抗血栓薬内服例も含めて）
胆と膵 41(2); 175-181, 2020.2
伊藤 鉄英、李 倫学、藤森 尚
【膵神経内分泌腫瘍-診断と治療のパラダイムシフト-】
薬物治療 膵神経内分泌腫瘍(NET)の薬剤選択
肝・胆・膵 78(1); 87-92, 2019.1
三木 正美、大野 隆真、藤森 尚、李 倫學、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】
膵炎各論 虚血性膵炎(解説/特集)
胆と膵 40(臨増特大); 1241-1245, 2019.11
五十嵐 久人、 藤森 尚、大野 隆真、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】
膵炎各論 薬剤性膵炎(解説/特集)
胆と膵 40(臨増特大); 1211-1214, 2019.11
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、松田 やよい、坂本 竜一、五十嵐 久人、伊藤 鉄英、小川 佳宏
【膵炎大全II～膵炎・Up to date～】
膵炎の治療 膵性糖尿病の診断と治療(解説/特集)
胆と膵 40(臨増特大); 1179-1183, 2019.11
肱岡 真之、大野 彰久、加来 豊馬、藤森 尚、大野 隆真、河邉 顕、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】
膵炎の治療 膵炎に対する生活指導および栄養療法の留意点(解説/特集)
胆と膵 40(臨増特大); 1173-1177, 2019.11
植田 圭二郎、下川 雄三、秋穂 裕唯、藤森 尚、大野 隆真、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】
膵炎の診断方法 膵炎における膵内分泌検査(解説/特集)
胆と膵 40(臨増特大); 1133-1137, 2019.11
藤森 尚、松本 一秀、三木 正美、寺松 克人、高松 悠、高岡 雄大、村上 正俊、末廣 侑大、大野隆真、荻野 治栄、伊原 栄吉、五十嵐 久人、古賀 裕、伊藤 鉄英、小川 佳宏
【膵・消化管神経内分泌腫瘍-診断・治療の基本と最新動向】
膵・消化管神経内分泌腫瘍画像診断のコツと生検の意義
臨床外科 74(9); 1042-1050, 2019.9
藤森 尚、伊藤 鉄英、大野 彰久、松本 一秀、寺松 克人、高松 悠、三木 正美、高岡 雄大、大野隆真、小川 佳宏
【内視鏡分類2019】
膵癌・膵神経内分泌腫瘍（膵嚢胞性腫瘍除く）
消化器内視鏡 31(4); 676-682, 2019.4
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、松田やよい、坂本 竜一、五十嵐 久人、伊藤 鉄英、小川 佳宏
膵性糖尿病の診断と治療
胆と膵 40; 1179-1183, 2019
Fujimori N, Ito T, Igarashi H, Oono T, Nakamura T, Niina Y, Hijioka M, Lee L, Uchida M, Takayanagi R.
Retroperitoneal fibrosis associated with immunoglobulin G4-related disease.
World J Gastroenterol. 19; 35-41, 2013
【自己免疫性膵炎とIgG4関連疾患における最新の知見】
自己免疫性膵炎におけるステロイド治療後の再燃の有無と縮小率の経時的変化
胆と膵 47(8); 795-799, 2026.8
藤森 尚、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【慢性膵炎診療の現状と課題】
膵外分泌機能不全診療の現状と課題
膵臓 41(1); 34-39, 2026.3
伊藤 鉄英、安森 翔、高松 悠、植田 圭二郎、平松 真祐、池田 純香、三嶋 一登、藤森 尚
【胆膵疾患国際診療ガイドラインのすべて～国内外ガイドラインの比較検証～】
慢性膵炎診療ガイドライン2021改訂第3版の概要と国際ガイドラインとの比較
胆と膵 47(3); 303-309, 2026.3
伊藤 鉄英、安森 翔、高松 悠、植田 圭二郎、村上 正俊、松本 一秀、五十嵐 久人、三嶋 一登、藤森 尚
【膵・消化管神経内分泌腫瘍(NEN)診療ガイドライン第3版とNEN Policy Recommendation】
トピックス 膵神経内分泌腫瘍に対する低酸素誘導因子HIF-2α阻害剤の治療薬としての可能性
胆と膵 47(2); 227-230, 2026.2
植田 圭二郎、帆北 理紗子、伊豆 将貴、古田 朗人、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、藤森 尚、伊藤 鉄英、小川 佳宏
【膵・消化管神経内分泌腫瘍(NEN)診療ガイドライン第3版とNEN Policy Recommendation】
膵機能性神経内分泌腫瘍の存在および局在診断 ガイドライン第3版改訂を受けて インスリノーマ
胆と膵 47(2); 153-157, 2026.2
村上 正俊、藤森 尚、帆北 理紗子、伊豆 将貴、末永 顕彦、上田 孝洋、梯 祥太郎、古田 朗人、大野 彰久、松本 一秀、植田 圭二郎、小川 佳宏
【ERCPトラブルシューティングを極める】
ERCPにおけるトラブルシューティング 各論:ERCP手技関連
十二指腸ステント留置に関するトラブル時の対応をどうする?【動画付】
胆と膵 46(臨増特大); 1249-1256, 2025.10
藤森 尚、末永 顕彦、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【膵疾患の診療】
(第1部)炎症性疾患 慢性膵炎 膵外分泌機能不全
臨床消化器内科 40(8); 895-901, 2025.7
松本 一秀、藤森 尚、赤木 健哉、川口 夢佳、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、安森 翔、村上 正俊、植田 圭二郎、伊藤 鉄英、小川 佳宏
【膵癌はナゼ治りにくいのか?】
膵癌治療の最前線 化学療法
臨牀と研究 102(4); 395-400, 2025.4
村上 正俊、藤森 尚、松本 一秀、植田 圭二郎、伊藤 鉄英、小川 佳宏
【膵・消化管神経内分泌腫瘍の診療アップデート】
膵神経内分泌腫瘍に対する薬物療法
臨床消化器内科 40(5); 576-583, 2025.4
植田 圭二郎、藤森 尚
【ここまでできる! プライマリケア-領域別で考えるプライマリケア医と専門医の役割】
(第7章)肝・胆・膵 腹痛,消化不良症,膵石灰化 慢性膵炎
内科 135(4); 892-897, 2025.4
藤森 尚、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、安森 翔、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【膵外分泌機能不全を再考する】
膵外分泌機能不全の原因と病態 慢性膵炎における膵外分泌機能不全
肝胆膵 90(2); 157-163, 2025.2
藤森 尚、末永 顕彦、川口 夢佳、赤木 健哉、上田 孝洋、梯 祥太郎、安森 翔、大野 彰久、松本 一秀、村上 正俊、植田 圭二郎、伊藤 鉄英、小川 佳宏
【膵外分泌機能不全を究める】
膵外分泌機能不全に伴う糖尿病の病態と治療
胆と膵 46(1); 55-60, 2025.1
高松 悠、伊藤 鉄英、三船 繭子、平賀 ちひろ、新名 雄介、岡本 亮子、植田 圭二郎、藤岡 真之、藤山 隆、藤森 尚
【膵外分泌機能不全を究める】
膵外分泌機能不全に対する栄養サポート
胆と膵 46(1); 61-64, 2025.01
村上 正俊、藤森 尚、宮ケ原 典、赤木 健哉、川口 夢佳、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、松本 一秀、植田 圭二郎、小川 佳宏
【希少領域、治療困難例における膵・胆道癌の薬物療法】
治療困難な膵・胆道癌の薬物療法 閉塞性・拘束性肺障害合併胆道癌・膵癌の薬物療法および薬剤性肺障害について
胆と膵 45(11); 1669-1675, 2024.11
藤森 尚、赤木 健哉、川口 夢佳、末永 顕彦、Gerodias Anthony R.、上田 孝洋、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【胆膵Interventional Endoscopyを極める】
トラブルシューティング 膵管ステント迷入
胆と膵 45(臨増特大); 1377-1383, 2024.10
藤森 尚、小森 康寛、末永 顕彦、植田 圭二郎、小川 佳宏
【スキルアップ内視鏡診療】胆膵 挿管・診断
経口胆道鏡をマスターする
消化器内視鏡 36(増刊号); 343-347, 2024.10
伊藤 鉄英、高松 悠、植田 圭二郎、村上 正俊、松本 一秀、藤森 尚
【膵胆道周囲の後腹膜腫瘍性病変の診断と治療】
膵胆道周囲の後腹膜腫瘍性病変 ～膵神経内分泌腫瘍～
胆と膵 45(9); 915-920, 2024.9
松本 一秀、藤森 尚、上田 孝洋、梯 祥太郎、大野 彰久、村上 正俊、植田 圭二郎、小川 佳宏
【今推しの肝胆膵研究手法と疾患モデル】
新規モデルによる肝胆膵研究 膵臓癌オルガノイドを用いたサブタイプ予測による予後解析
肝胆膵 89(2); 243-248, 2024.8
松本 一秀、藤森 尚、小川 佳宏
オルガノイド研究で膵がん治療を革新したい
国際医薬品情報 1255; 22-23, 2024.8
大野 彰久、藤森 尚、小森 康寛、末永 顕彦、梯 祥太郎、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、小川 佳宏
【日常診療での超音波検査のおさえどころ】
超音波検査の最新の進歩 胆膵のInterventional EUS
臨牀と研究 101(7); 58-59, 2024.7
藤森 尚（回答者）、松本 和幸（質問者；岡山大学病院消化器内科）
小径かつ低悪性度の膵神経内分泌腫瘍に対して経過観察した場合のデータは？経過観察は許容される？
週刊 日本医事新報 No.5215; 50-51, 2024.4
藤森 尚、村上 正俊、松本 一秀、大野 彰久、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
【超高齢社会（高齢化率21％以上）の膵疾患診療】
超高齢社会における膵神経内分泌腫瘍診断療
膵臓 39(1); 33-42, 2024.2
村上 正俊、藤森 尚、末永 顕彦、小森 康寛、梯 祥太郎、大野 彰久、松本 一秀、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
【神経内分泌腫瘍の新たな知見〜膵消化管神経内分泌腫瘍診療ガイドライン改定に向けて〜】
膵・消化管神経内分泌腫瘍におけるliquid biopsy診断
胆と膵 45(1); 25-31, 2024.1
藤森 尚、村上 正俊、蓑田 洋介、植田 圭二郎、伊藤 鉄英、小川 佳宏
【神経内分泌腫瘍の新たな知見〜膵消化管神経内分泌腫瘍診療ガイドライン改定に向けて〜】
AIを用いた膵神経内分泌腫瘍治療切除後再発予測モデルの構築と分析
胆と膵 45(1); 85-93, 2024.1
藤森 尚、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、伊藤 心二、吉住 朋晴、池永 直樹、仲田 興平、中村 雅史、小川 佳宏
【Stenting Bible～Renewal～ステントと挿入・留置手技にこだわる!!】炎症・液体貯留に対するStenting Strategy
術後膵液瘻に対するStenting Strategy
胆と膵 44(臨時増刊号); 1215-1221, 2023.10
大野 彰久、藤森 尚、寺松 克人、植田 圭二郎、小川 佳宏
【胆膵の画像・内視鏡診断の進歩-早期診断と正確な診断のために】
慢性膵炎の画像診断の進歩
臨牀消化器内科 38(13); 1632-1639, 2023.11
植田 圭二郎、伊藤 鉄英、河村 康平、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、藤森 尚、小川 佳宏
【胆道癌と膵癌のリスクファクター】
飲酒と発がん
胆と膵 44(9); 815-819, 2023.9
植田 圭二郎、藤森 尚
膵癌患者における糖尿病
胆と膵 44(9); 815-819, 2023.9
藤森 尚、大野 彰久、小森 康寛、松本 一秀、村上 正俊、寺松 克人、竹野 歩、植田 圭二郎、小川 佳宏
【胆膵疾患の内視鏡治療-beyond the ガイドライン!!】
慢性膵炎の合併症に対する内視鏡治療
消化器クリニカルアップデート 5(1); 53-60, 2023.6
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
【ソマトスタチン受容体を介した膵神経内分泌腫瘍の診断と治療の進歩】
ランレオチドによる膵NETに対する抗腫瘍治療
胆と膵 44(1); 53-59, 2023.1
藤森 尚、大野 彰久、植田 圭二郎、蓑田 洋介、小川 佳宏
【胆膵EUSのトラブルシューティング】
治療的EUS Peripancreatic/pancreatic fluid collection(PFD)ドレナージ ステントが迷入してしまった
消化器内視鏡 34(12); 1976-1980, 2022.12
伊藤 鉄英、高松 悠、植田 圭二郎、藤森 尚
【消化器領域の神経内分泌腫瘍の最新の知見】
膵・消化管神経内分泌腫瘍診療ガイドライン2019(第2版)
消化器内科 4(9); 29-34, 2022.10
藤森 尚、小川 佳宏
【エキスパートがお答えします!日常臨床のあるあるの疑問】
(第5章)肝・胆・膵
慢性膵炎の患者にはどのような生活指導が必要でしょうか？
内科 130(3); 502-505 2022.9
藤森 尚、松本 一秀、寺松 克人、竹野 歩、小川 佳宏
【胆道・膵疾患を診る-早期診断・早期治療のために】
胆膵疾患の総ざらい 慢性膵炎
内科 130(1); 77-83, 2022.7
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、竹野 歩、植田 圭二郎、伊藤 鉄英、小川 佳宏
【膵神経内分泌腫瘍-新たなる胎動2022-】基礎研究
膵神経内分泌腫瘍のリキッドバイオプシー
肝胆膵 84(6); 745-750, 2022.6
藤森 尚、大野 彰久、松本 一秀、村上 正俊、寺松 克人、竹野 歩、大野 隆真、小川 佳宏
【ブラッシュアップ!膵臓疾患の臨床検査】
膵臓の画像診断（CT・MRI・超音波内視鏡）
Medical Technology 50(5); 481-487, 2022.5
伊藤 鉄英、植田 圭二郎、高松 悠、松本 一秀、寺松 克人、竹野 歩、藤森 尚
【診療ガイドライン改訂後の膵炎診療】
慢性膵炎診療ガイドライン2021の改訂のポイント
肝胆膵 84(3); 321-328, 2022.3
村上 正俊、藤森 尚、上田 孝洋、大野 彰久、松本 一秀、寺松 克人、高松 悠、竹野 歩、大野 隆真、伊藤 鉄英、小川 佳宏
【膵神経内分泌腫瘍の病態解明と診療戦略】
膵神経内分泌腫瘍におけるLiquid biopsy診断と治療への応用
胆と膵 43(2); 141-145, 2022.2
藤森 尚、寺松 克人、高松 悠、上田 孝洋、平畠 啓介、大野 彰久、村上 正俊、安森 翔、松本 一秀、竹野 歩、大野 隆真、小川 佳宏
【Liquid biopsyは膵癌の診断・治療をどう変えるか?】
Liquid biopsyの膵癌切除後のサーベイランスへの応用
胆と膵 43(1); 71-75, 2022.1
伊藤 鉄英、植田 圭二郎、李 倫學、伊藤 寛治、藤森 尚
【膵・胆道癌における薬物療法のすべて】
がん薬物療法のエビデンス 膵神経内分泌腫瘍の薬物療法
胆と膵 42(臨増特大); 1167-1170, 2021.11
蓑田 洋介、長友 周三郎、西岡 慧、江崎 充、荻野 治栄、藤森 尚、大野 隆真、伊原 栄吉、大久保 文彦、佐々木 泰介、小田 義直、小川 佳宏
【膵と胆道の先天性形成異常～発生から臨床まで～】
異所性膵の診断
胆と膵 42(10); 943-946, 2021.10
新名 雄介、伊藤 鉄英、藤森 尚
【膵臓症候群(第3版)-その他の膵臓疾患を含めて-】
基本的な膵検査 膵内分泌能検査
日本臨床 別冊膵臓症候群; 15-16, 2021.6
藤森 尚、村上 正俊、松本 一秀、寺松 克人、高松 悠、竹野 歩、原 真児登、梯 祥太郎、 安森 翔、大野 隆真
膵・消化管神経内分泌腫瘍を巡る最近の話題
NEN診断と治療の新時代 膵・消化管神経内分泌腫瘍(GEP-NEN)の診断の進歩
Pharma Medica 39(5); 66-72, 2021.5
藤森 尚、原 真児登、梯 祥太郎、安森 翔、村上 正俊、松本 一秀、寺松 克人、高松 悠、竹野 歩、大野 隆真、伊藤 鉄英、小川 佳宏
【慢性膵炎診療の最前線】
慢性膵炎に対する薬物治療
胆と膵 42; 113-116, 2021.2
伊藤 鉄英、新名 雄介、李 倫學、藤森 尚、大野 隆真
【内分泌腺腫瘍(第2版)-基礎・臨床研究のアップデート-】
消化管神経内分泌腫瘍 消化管神経内分泌腫瘍の疫学
日本臨床 78(増刊4 内分泌腺腫瘍); 770-773, 2020.9
高松 悠、大野 隆真、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高岡 雄大、藤森 尚、上田 詩織、本坂亜希子、吉澤 裕子、南 晴奈、上野 寿弥、國栖 真理、横山 富美子、盛永 彩香、花田 浩和、濵﨑 正子
慢性膵炎患者に対する多職種連携のサポーティブ・ケアの試み
膵臓 35; 180-186, 2020
藤森 尚、高松 悠、松本 一秀、寺松 克人、大野 隆真、小川 佳宏
【慢性膵炎-ガイドライン改訂に向けて】
慢性膵炎の病態（1）成因、疫学
臨床消化器内科 35(11); 1297-1302, 2020.9
藤森 尚、村上 正俊、末廣 侑大、松本 一秀、寺松 克人、高松 悠、高岡 雄大、竹野 歩、大野 隆真、小川 佳宏
【膵炎・膵がん診療のUp To Date】
膵癌の日常診療－診断の進め方
臨床と研究 97(5); 537-542, 2020.5
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、伊藤 鉄英、小川 佳宏
【慢性膵炎診療2020】基礎研究・病態
喫煙と慢性膵炎の関係－基礎研究と疫学調査のデータから－
肝胆膵 80(2); 259-263, 2020.2
藤森 尚、松本 一秀、村上 正俊、加来 豊馬、末廣 侑大、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、森 泰寿、大塚 隆生、小川 佳宏
【胆膵疾患における緊急内視鏡～リスクマネジメントも含めて～】
EST後出血（抗血栓薬内服例も含めて）
胆と膵 41(2); 175-181, 2020.2
伊藤 鉄英、李 倫学、藤森 尚
【膵神経内分泌腫瘍-診断と治療のパラダイムシフト-】
薬物治療 膵神経内分泌腫瘍(NET)の薬剤選択
肝・胆・膵 78(1); 87-92, 2019.1
三木 正美、大野 隆真、藤森 尚、李 倫學、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】
膵炎各論 虚血性膵炎(解説/特集)
胆と膵 40(臨増特大); 1241-1245, 2019.11
五十嵐 久人、 藤森 尚、大野 隆真、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】
膵炎各論 薬剤性膵炎(解説/特集)
胆と膵 40(臨増特大); 1211-1214, 2019.11
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、松田 やよい、坂本 竜一、五十嵐 久人、伊藤 鉄英、小川 佳宏
【膵炎大全II～膵炎・Up to date～】
膵炎の治療 膵性糖尿病の診断と治療(解説/特集)
胆と膵 40(臨増特大); 1179-1183, 2019.11
肱岡 真之、大野 彰久、加来 豊馬、藤森 尚、大野 隆真、河邉 顕、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】
膵炎の治療 膵炎に対する生活指導および栄養療法の留意点(解説/特集)
胆と膵 40(臨増特大); 1173-1177, 2019.11
植田 圭二郎、下川 雄三、秋穂 裕唯、藤森 尚、大野 隆真、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】
膵炎の診断方法 膵炎における膵内分泌検査(解説/特集)
胆と膵 40(臨増特大); 1133-1137, 2019.11
藤森 尚、松本 一秀、三木 正美、寺松 克人、高松 悠、高岡 雄大、村上 正俊、末廣 侑大、大野隆真、荻野 治栄、伊原 栄吉、五十嵐 久人、古賀 裕、伊藤 鉄英、小川 佳宏
【膵・消化管神経内分泌腫瘍-診断・治療の基本と最新動向】
膵・消化管神経内分泌腫瘍画像診断のコツと生検の意義
臨床外科 74(9); 1042-1050, 2019.9
藤森 尚、伊藤 鉄英、大野 彰久、松本 一秀、寺松 克人、高松 悠、三木 正美、高岡 雄大、大野隆真、小川 佳宏
【内視鏡分類2019】
膵癌・膵神経内分泌腫瘍（膵嚢胞性腫瘍除く）
消化器内視鏡 31(4); 676-682, 2019.4
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、松田やよい、坂本 竜一、五十嵐 久人、伊藤 鉄英、小川 佳宏
膵性糖尿病の診断と治療
胆と膵 40; 1179-1183, 2019
Fujimori N, Ito T, Igarashi H, Oono T, Nakamura T, Niina Y, Hijioka M, Lee L, Uchida M, Takayanagi R.
Retroperitoneal fibrosis associated with immunoglobulin G4-related disease.
World J Gastroenterol. 19; 35-41, 2013